Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	double-stranded methylated DNA binding	MBD1 EGR1 ZNF445	4.84e-05	7	226	3	GO:0010385
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DAB2IP MYO9A EPS8L1 DENND1C ARHGEF17 RCC2 CDC42EP2 HERC1 MCF2L ARAP1 AGAP3 KALRN RGL3 TBC1D10B KNDC1 PSD4	2.28e-04	507	226	16	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DAB2IP MYO9A EPS8L1 DENND1C ARHGEF17 RCC2 CDC42EP2 HERC1 MCF2L ARAP1 AGAP3 KALRN RGL3 TBC1D10B KNDC1 PSD4	2.28e-04	507	226	16	GO:0030695
GeneOntologyMolecularFunction	cytoskeletal protein binding	HIP1 MAP1A MYO9A PDLIM7 MYOC SPTBN2 SYNPO2L EPS8L1 ADGRV1 DYSF ACE CCDC88B KIF24 RCC2 SPTBN5 COBL GNAS UTRN ANK3 KIF26B BRSK2 CCDC61 EML3 GAS2L2 DIXDC1 NIN	3.09e-04	1099	226	26	GO:0008092
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	EPS8L1 DENND1C ARHGEF17 RCC2 HERC1 MCF2L KALRN RGL3 KNDC1 PSD4	3.14e-04	231	226	10	GO:0005085
GeneOntologyMolecularFunction	phosphatidate phosphatase activity	LPIN1 LPIN3 LPIN2	4.75e-04	14	226	3	GO:0008195
Domain	FN3_dom	IGFN1 SPEG MDGA2 IL22RA1 KIAA0319 PTPRH PTPRJ UMODL1 ROBO3 KALRN FNDC3A IFNLR1 POMGNT2 TNXB EPHA1 IL9R EPHA7	5.45e-10	209	222	17	IPR003961
Domain	FN3	IGFN1 SPEG MDGA2 IL22RA1 PTPRH PTPRJ UMODL1 ROBO3 KALRN FNDC3A IFNLR1 POMGNT2 TNXB EPHA1 IL9R EPHA7	2.11e-09	199	222	16	PS50853
Domain	Ig-like_fold	IGFN1 SIGLEC9 SPEG SIGLEC5 MDGA2 IL22RA1 KIAA0319 CILP2 HMCN2 PTPRH PTPRJ UMODL1 NFATC4 ROBO3 SLAMF9 KALRN SIGLEC14 PAPLN FNDC3A IFNLR1 CD1C POMGNT2 NCAN TNXB EPHA1 IL9R EPHA7	9.02e-08	706	222	27	IPR013783
Domain	LNS2	LPIN1 PITPNM1 LPIN3 LPIN2	2.86e-07	6	222	4	IPR013209
Domain	LNS2	LPIN1 PITPNM1 LPIN3 LPIN2	2.86e-07	6	222	4	SM00775
Domain	LNS2	LPIN1 PITPNM1 LPIN3 LPIN2	2.86e-07	6	222	4	PF08235
Domain	LNS2/PITP	LPIN1 PITPNM1 LPIN3 LPIN2	2.86e-07	6	222	4	IPR031315
Domain	-	IGFN1 SIGLEC9 SPEG SIGLEC5 MDGA2 IL22RA1 CILP2 PTPRJ UMODL1 NFATC4 ROBO3 SLAMF9 KALRN SIGLEC14 PAPLN FNDC3A IFNLR1 CD1C POMGNT2 NCAN TNXB EPHA1 IL9R EPHA7	1.31e-06	663	222	24	2.60.40.10
Domain	Ago_hook	TNRC6B TNRC6A TNRC6C	1.66e-06	3	222	3	PF10427
Domain	Lipin_N	LPIN1 LPIN3 LPIN2	1.66e-06	3	222	3	IPR007651
Domain	Lipin_mid	LPIN1 LPIN3 LPIN2	1.66e-06	3	222	3	IPR031703
Domain	Lipin_N	LPIN1 LPIN3 LPIN2	1.66e-06	3	222	3	PF04571
Domain	TNRC6_PABC-bd	TNRC6B TNRC6A TNRC6C	1.66e-06	3	222	3	IPR032226
Domain	Argonaute_hook_dom	TNRC6B TNRC6A TNRC6C	1.66e-06	3	222	3	IPR019486
Domain	Lipin_mid	LPIN1 LPIN3 LPIN2	1.66e-06	3	222	3	PF16876
Domain	TNRC6-PABC_bdg	TNRC6B TNRC6A TNRC6C	1.66e-06	3	222	3	PF16608
Domain	FN3	IGFN1 SPEG KIAA0319 PTPRH PTPRJ UMODL1 ROBO3 KALRN FNDC3A TNXB EPHA1 EPHA7	2.26e-06	185	222	12	SM00060
Domain	PH_dom-like	DAB2IP SPTBN2 ANKS1B APBB3 EPS8L1 ARHGEF17 SPTBN5 MCF2L ARAP1 TECPR1 AGAP3 IRS4 KALRN STAP2 APBA3 TNS2 PLCH1 PSD4	3.64e-06	426	222	18	IPR011993
Domain	fn3	IGFN1 SPEG PTPRH PTPRJ UMODL1 ROBO3 KALRN FNDC3A TNXB EPHA1 EPHA7	3.88e-06	162	222	11	PF00041
Domain	-	DAB2IP SPTBN2 ANKS1B APBB3 ARHGEF17 SPTBN5 MCF2L ARAP1 TECPR1 AGAP3 IRS4 KALRN STAP2 APBA3 TNS2 PLCH1 PSD4	4.68e-06	391	222	17	2.30.29.30
Domain	Spectrin	SPTBN2 SPTBN5 MCF2L UTRN KALRN	6.41e-06	23	222	5	PF00435
Domain	Spectrin_repeat	SPTBN2 SPTBN5 MCF2L UTRN KALRN	2.13e-05	29	222	5	IPR002017
Domain	SPEC	SPTBN2 SPTBN5 MCF2L UTRN KALRN	3.52e-05	32	222	5	SM00150
Domain	Spectrin/alpha-actinin	SPTBN2 SPTBN5 MCF2L UTRN KALRN	3.52e-05	32	222	5	IPR018159
Domain	RA	MYO9A DGKQ RASIP1 ARAP1 RGL3	6.33e-05	36	222	5	PF00788
Domain	RA	MYO9A DGKQ RASIP1 ARAP1 RGL3	7.25e-05	37	222	5	PS50200
Domain	RA_dom	MYO9A DGKQ RASIP1 ARAP1 RGL3	1.06e-04	40	222	5	IPR000159
Domain	PTB	ANKS1B APBB3 EPS8L1 APBA3 TNS2	1.06e-04	40	222	5	SM00462
Domain	PTB/PI_dom	ANKS1B APBB3 EPS8L1 APBA3 TNS2	1.20e-04	41	222	5	IPR006020
Domain	PH	DAB2IP SPTBN2 SPTBN5 MCF2L ARAP1 TECPR1 AGAP3 IRS4 KALRN STAP2 PLCH1 PSD4	1.29e-04	278	222	12	SM00233
Domain	PH_dom-spectrin-type	SPTBN2 SPTBN5 PSD4	1.32e-04	9	222	3	IPR001605
Domain	PH_DOMAIN	DAB2IP SPTBN2 SPTBN5 MCF2L ARAP1 TECPR1 AGAP3 IRS4 KALRN STAP2 PLCH1 PSD4	1.34e-04	279	222	12	PS50003
Domain	PH_domain	DAB2IP SPTBN2 SPTBN5 MCF2L ARAP1 TECPR1 AGAP3 IRS4 KALRN STAP2 PLCH1 PSD4	1.38e-04	280	222	12	IPR001849
Domain	M_domain	TNRC6A TNRC6C	1.41e-04	2	222	2	PF12938
Domain	GW182_M_dom	TNRC6A TNRC6C	1.41e-04	2	222	2	IPR026805
Domain	SAM_1	ANKS1B KIF24 DDHD2 ARAP1 EPHA1 EPHA7	1.56e-04	68	222	6	PF00536
Domain	WW	APBB3 SAV1 PRPF40B UTRN CEP164	2.56e-04	48	222	5	SM00456
Domain	EGF-like_CS	ADAM20 HMCN2 UMODL1 IMPG2 ZAN PRF1 CSPG5 NCAN TNXB EPHA1 EPHA7	3.02e-04	261	222	11	IPR013032
Domain	WW_DOMAIN_1	APBB3 SAV1 PRPF40B UTRN CEP164	3.41e-04	51	222	5	PS01159
Domain	WW_DOMAIN_2	APBB3 SAV1 PRPF40B UTRN CEP164	3.41e-04	51	222	5	PS50020
Domain	EGF_2	ADAM20 HMCN2 UMODL1 IMPG2 ZAN PRF1 CSPG5 NCAN TNXB EPHA1 EPHA7	3.44e-04	265	222	11	PS01186
Domain	WW_dom	APBB3 SAV1 PRPF40B UTRN CEP164	3.74e-04	52	222	5	IPR001202
Domain	WTX	AMER2 AMER3	4.19e-04	3	222	2	PF09422
Domain	FAM53	FAM53C FAM53A	4.19e-04	3	222	2	IPR029356
Domain	FAM53	FAM53C FAM53A	4.19e-04	3	222	2	PF15242
Domain	Uncharacterised_FAM123	AMER2 AMER3	4.19e-04	3	222	2	IPR019003
Domain	Ig_I-set	IGFN1 SPEG MDGA2 CILP2 HMCN2 ROBO3 KALRN SIGLEC14 PAPLN	4.61e-04	190	222	9	IPR013098
Domain	I-set	IGFN1 SPEG MDGA2 CILP2 HMCN2 ROBO3 KALRN SIGLEC14 PAPLN	4.61e-04	190	222	9	PF07679
Domain	RA	MYO9A DGKQ RASIP1 RGL3	4.75e-04	31	222	4	SM00314
Domain	IGc2	IGFN1 SPEG SIGLEC5 MDGA2 CILP2 HMCN2 ROBO3 KALRN SIGLEC14 PAPLN	5.25e-04	235	222	10	SM00408
Domain	Ig_sub2	IGFN1 SPEG SIGLEC5 MDGA2 CILP2 HMCN2 ROBO3 KALRN SIGLEC14 PAPLN	5.25e-04	235	222	10	IPR003598
Domain	DysFC	DYSF TECPR1	8.31e-04	4	222	2	SM00694
Domain	DysFN	DYSF TECPR1	8.31e-04	4	222	2	SM00693
Domain	Peroxin/Ferlin	DYSF TECPR1	8.31e-04	4	222	2	IPR006614
Domain	SAM_DOMAIN	ANKS1B KIF24 DDHD2 ARAP1 EPHA1 EPHA7	9.50e-04	95	222	6	PS50105
Domain	UBA-like	TNRC6B TNRC6A RHBDD3 TNRC6C CBL	9.78e-04	64	222	5	IPR009060
Domain	CH	SPTBN2 SPTBN5 UTRN GAS2L2 DIXDC1	1.05e-03	65	222	5	SM00033
Domain	SAM	ANKS1B KIF24 DDHD2 ARAP1 EPHA1 EPHA7	1.06e-03	97	222	6	IPR001660
Domain	NUT	NUTM2A NUTM2B	1.37e-03	5	222	2	IPR024310
Domain	NUT_N	NUTM2A NUTM2B	1.37e-03	5	222	2	IPR024309
Domain	NUT	NUTM2A NUTM2B	1.37e-03	5	222	2	PF12881
Domain	PLAC	PAPLN ADAMTS12 ADAMTS7	1.39e-03	19	222	3	PS50900
Domain	PLAC	PAPLN ADAMTS12 ADAMTS7	1.39e-03	19	222	3	IPR010909
Domain	CH	SPTBN2 SPTBN5 UTRN GAS2L2 DIXDC1	1.47e-03	70	222	5	PF00307
Domain	PDZ	IL16 PDLIM7 SYNPO2L GRID2IP LNX2 APBA3 SCRIB	1.50e-03	141	222	7	PF00595
Domain	-	SPTBN2 SPTBN5 UTRN GAS2L2 DIXDC1	1.56e-03	71	222	5	1.10.418.10
Domain	IG	IGFN1 SIGLEC9 SPEG SIGLEC5 MDGA2 CILP2 HMCN2 ROBO3 SLAMF9 KALRN SIGLEC14 PAPLN NCAN	1.64e-03	421	222	13	SM00409
Domain	Ig_sub	IGFN1 SIGLEC9 SPEG SIGLEC5 MDGA2 CILP2 HMCN2 ROBO3 SLAMF9 KALRN SIGLEC14 PAPLN NCAN	1.64e-03	421	222	13	IPR003599
Domain	-	ANKS1B KIF24 DDHD2 ARAP1 EPHA1 EPHA7	1.67e-03	106	222	6	1.10.150.50
Domain	CH	SPTBN2 SPTBN5 UTRN GAS2L2 DIXDC1	1.77e-03	73	222	5	PS50021
Domain	PDZ	IL16 PDLIM7 SYNPO2L GRID2IP LNX2 APBA3 SCRIB	1.98e-03	148	222	7	SM00228
Domain	CH-domain	SPTBN2 SPTBN5 UTRN GAS2L2 DIXDC1	1.99e-03	75	222	5	IPR001715
Domain	EPTP	ADGRV1 LGI2	2.04e-03	6	222	2	PF03736
Domain	DDHD	DDHD2 PITPNM1	2.04e-03	6	222	2	PF02862
Domain	DDHD	DDHD2 PITPNM1	2.04e-03	6	222	2	PS51043
Domain	EPTP	ADGRV1 LGI2	2.04e-03	6	222	2	IPR005492
Domain	DDHD_dom	DDHD2 PITPNM1	2.04e-03	6	222	2	IPR004177
Domain	DDHD	DDHD2 PITPNM1	2.04e-03	6	222	2	SM01127
Domain	EGF_3	ADAM20 HMCN2 UMODL1 IMPG2 ZAN PRF1 CSPG5 NCAN TNXB	2.05e-03	235	222	9	PS50026
Domain	-	IL16 PDLIM7 SYNPO2L GRID2IP LNX2 APBA3 SCRIB	2.14e-03	150	222	7	2.30.42.10
Domain	-	RCC2 HERC1 TECPR1	2.16e-03	22	222	3	2.130.10.30
Domain	SEA	UMODL1 IMPG2 MUC16	2.16e-03	22	222	3	PF01390
Domain	PDZ	IL16 PDLIM7 SYNPO2L GRID2IP LNX2 APBA3 SCRIB	2.22e-03	151	222	7	PS50106
Domain	PDZ	IL16 PDLIM7 SYNPO2L GRID2IP LNX2 APBA3 SCRIB	2.30e-03	152	222	7	IPR001478
Domain	IG_LIKE	IGFN1 SIGLEC9 SPEG SIGLEC5 MDGA2 CILP2 HMCN2 ROBO3 SLAMF9 KALRN SIGLEC14 PAPLN CD1C NCAN	2.31e-03	491	222	14	PS50835
Domain	WW	APBB3 SAV1 PRPF40B UTRN	2.32e-03	47	222	4	PF00397
Domain	ACTININ_2	SPTBN2 SPTBN5 UTRN	2.46e-03	23	222	3	PS00020
Domain	ACTININ_1	SPTBN2 SPTBN5 UTRN	2.46e-03	23	222	3	PS00019
Domain	ADAM_spacer1	PAPLN ADAMTS12 ADAMTS7	2.46e-03	23	222	3	IPR010294
Domain	Actinin_actin-bd_CS	SPTBN2 SPTBN5 UTRN	2.46e-03	23	222	3	IPR001589
Domain	SEA	UMODL1 IMPG2 MUC16	2.46e-03	23	222	3	PS50024
Domain	ADAM_spacer1	PAPLN ADAMTS12 ADAMTS7	2.46e-03	23	222	3	PF05986
Domain	SEA_dom	UMODL1 IMPG2 MUC16	2.46e-03	23	222	3	IPR000082
Domain	RCC1/BLIP-II	RCC2 HERC1 TECPR1	2.46e-03	23	222	3	IPR009091
Domain	SAM/pointed	ANKS1B KIF24 DDHD2 ARAP1 EPHA1 EPHA7	2.76e-03	117	222	6	IPR013761
Domain	Peptidase_M12B_ADAM-TS	PAPLN ADAMTS12 ADAMTS7	2.79e-03	24	222	3	IPR013273
Domain	EAR	ADGRV1 LGI2	2.84e-03	7	222	2	IPR009039
Domain	EAR	ADGRV1 LGI2	2.84e-03	7	222	2	PS50912
Domain	Ig-like_dom	IGFN1 SIGLEC9 SPEG SIGLEC5 MDGA2 CILP2 HMCN2 ROBO3 SLAMF9 KALRN SIGLEC14 PAPLN CD1C NCAN	2.87e-03	503	222	14	IPR007110
Domain	EGF-like_dom	ADAM20 HMCN2 UMODL1 IMPG2 ZAN PRF1 CSPG5 NCAN TNXB	3.03e-03	249	222	9	IPR000742
Pathway	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	LPIN1 GPAT2 LPIN3 LPIN2	5.41e-06	12	148	4	MM15447
Pathway	REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION	TNRC6B TNRC6A TNRC6C NR3C1	7.75e-06	13	148	4	M46434
Pathway	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	LPIN1 GPAT2 LPIN3 LPIN2	1.08e-05	14	148	4	M619
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	TNRC6B TNRC6A TNRC6C	3.85e-05	7	148	3	M46421
Pathway	REACTOME_TRIGLYCERIDE_METABOLISM	LPIN1 GPAT2 LPIN3 LPIN2	8.84e-05	23	148	4	MM15575
Pathway	REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	TNRC6B TNRC6A TNRC6C	9.09e-05	9	148	3	M27810
Pathway	REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION	TNRC6B TNRC6A TNRC6C	9.09e-05	9	148	3	M46436
Pathway	REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS	TNRC6B TNRC6A TNRC6C	1.29e-04	10	148	3	M48013
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	DAB2IP SPTBN2 TNRC6B SPTBN5 TNRC6A FGA CDC42EP2 FOXO3 KALRN RGL3 TNRC6C ARAF	1.72e-04	327	148	12	M27565
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	LPIN1 DDHD2 GPAT2 PITPNM1 LPIN3 PLA2R1 LPIN2 PIK3R5 INPP5J	2.25e-04	196	148	9	MM14591
Pathway	REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA	LPIN1 LPIN3 LPIN2	2.33e-04	12	148	3	MM15105
Pathway	REACTOME_SYNTHESIS_OF_PE	LPIN1 LPIN3 LPIN2	2.33e-04	12	148	3	MM14586
Pathway	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	LPIN1 DDHD2 GPAT2 PITPNM1 LPIN3 PLA2R1 LPIN2	2.70e-04	120	148	7	MM14585
Pathway	REACTOME_SYNTHESIS_OF_PE	LPIN1 LPIN3 LPIN2	3.00e-04	13	148	3	M656
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	TNRC6B TNRC6A ZC3H12A TNRC6C	3.34e-04	32	148	4	M48012
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	LPIN1 DDHD2 GPAT2 PITPNM1 LPIN3 PLA2R1 LPIN2 PIK3R5 INPP5J	3.87e-04	211	148	9	M649
Pathway	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	LPIN1 DDHD2 GPAT2 PITPNM1 LPIN3 PLA2R1 LPIN2	4.00e-04	128	148	7	M706
Pathway	PID_EPHA_FWDPATHWAY	CBL PIK3R5 EPHA1 EPHA7	4.23e-04	34	148	4	M177
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	TNRC6B TNRC6A TNRC6C NR3C1	4.23e-04	34	148	4	M46422
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	TNRC6B TNRC6A CDC42EP2 FOXO3 KALRN TNRC6C	4.35e-04	93	148	6	M27572
Pathway	REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA	LPIN1 LPIN3 LPIN2	4.70e-04	15	148	3	M27360
Pathway	REACTOME_TRIGLYCERIDE_METABOLISM	LPIN1 GPAT2 LPIN3 LPIN2	6.52e-04	38	148	4	M27856
Pathway	REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY	TNRC6B TNRC6A TNRC6C	6.92e-04	17	148	3	M27788
Pathway	WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY	LPIN1 LPIN3 LPIN2	8.24e-04	18	148	3	M42546
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP STK36 HIP1 SPEG APBB3 DGKQ TTC3 DYSF PRAG1 ABCA7 WIZ COBL HERC1 MCF2L DMWD BRAT1 MYRF ARAP1 AGAP3 FOXO3 DPH2 KALRN UBR4 PAPLN TNRC6C EML3 WDR59 NR2F2 IFNLR1 LPIN3 POMGNT2 ADAMTS7 LTK PRRT4 TOP3A	2.22e-14	1105	232	35	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDK17 MYO9A MBD1 CHEK1 ARHGEF17 PRAG1 FAM53C COBL GNAS PPIP5K2 UTRN AGAP3 FOXO3 IRS4 KIF26B BRSK2 CBL WDR26 WDR59 ARAF LPIN3 TBC1D10B SCRIB PLCH1 TSSK1B CSPP1	1.77e-10	861	232	26	36931259
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CDK17 PDLIM7 SAV1 TNRC6B NFATC4 TNRC6A UTRN HSPA4 AGAP3 FOXO3 IRS4 LNX2 CBL ARAF FAM193A CSPP1 PPP6R3 NIN	1.53e-09	446	232	18	24255178
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP1A MYO9A TNRC6B TNRC6A COBL DDHD2 UTRN KIF26B FAM193A SCRIB PPP6R3	1.84e-07	209	232	11	36779422
Pubmed	A human MAP kinase interactome.	SP100 MAP1A MYO9A SPTBN2 NCKAP5 CCDC88B FAM53C TNRC6A CDC42EP2 COBL ANK3 KIF26B NUP98 CBL ARAF EGR1	2.08e-07	486	232	16	20936779
Pubmed	Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	18694939
Pubmed	Lipin proteins form homo- and hetero-oligomers.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	20735359
Pubmed	Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	22481384
Pubmed	Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	17158099
Pubmed	Gawky is a component of cytoplasmic mRNA processing bodies required for early Drosophila development.	TNRC6B TNRC6A TNRC6C	2.93e-07	3	232	3	16880270
Pubmed	Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	10884287
Pubmed	Identification of lipidomic profiles associated with drug-resistant prostate cancer cells.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	33596934
Pubmed	Expression of TNRC6 (GW182) Proteins Is Not Necessary for Gene Silencing by Fully Complementary RNA Duplexes.	TNRC6B TNRC6A TNRC6C	2.93e-07	3	232	3	31670606
Pubmed	Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	30507612
Pubmed	Lipin-1 and lipin-3 together determine adiposity in vivo.	LPIN1 LPIN3 LPIN2	2.93e-07	3	232	3	24634820
Pubmed	Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing.	TNRC6B TNRC6A TNRC6C	2.93e-07	3	232	3	34108231
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SP100 IL16 MAP1A MBD1 TNRC6B CHEK1 FAM53C ABCA7 ZNF469 WIZ HMCN2 PRPF40B TNRC6A ZNF324 AGAP3 P3H3 WDR26 ARAF TBC1D10B ZFHX4 ZBTB10 SCRIB LTK NIN	5.42e-07	1116	232	24	31753913
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DAB2IP PDLIM7 SPTBN2 DHX38 WIZ PTPRH PTPRJ TNRC6A HERC1 DMWD UTRN PRRC2A IRS4 ANK3 NUP98 TNS2 CCDC61 TBC1D10B CSPG5 SCRIB CSPP1 PPP6R3 NIN	6.81e-07	1049	232	23	27880917
Pubmed	Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing.	TNRC6B TNRC6A TNRC6C	1.17e-06	4	232	3	21063388
Pubmed	Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin.	LPIN1 LPIN3 LPIN2	1.17e-06	4	232	3	11138012
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	STK36 MAP1A PDLIM7 ZNF469 NFATC4 ARAP1 TECPR1 IRS4 ANK3 PHF23 UBR4 NUP98 FAM193A EGR1	1.38e-06	430	232	14	35044719
Pubmed	Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.	GNAS HERC1 AGAP3 FNDC3A WDR59 ARAF EPHA7 NIN	4.62e-06	139	232	8	25476789
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	CARMIL3 KIF24 TRANK1 USP51 TNRC6A GNAS UTRN KALRN MUC16 CR1 ADAMTS12 PLA2R1 FAM193A ITPRIP TNXB	5.29e-06	552	232	15	10737800
Pubmed	The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins.	TNRC6B TNRC6A TNRC6C	1.01e-05	7	232	3	19383768
Pubmed	Functional dissection of the human TNRC6 (GW182-related) family of proteins.	TNRC6B TNRC6A TNRC6C	1.01e-05	7	232	3	19470757
Pubmed	The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils.	SIGLEC9 SIGLEC5 SIGLEC14	1.01e-05	7	232	3	15048729
Pubmed	[Functions and molecular evolution of Siglecs, a family of sialic acid receptor proteins].	SIGLEC9 SIGLEC5 SIGLEC14	1.01e-05	7	232	3	18453149
Pubmed	Genome-wide association study reveals two new risk loci for bipolar disorder.	TRANK1 ANK3 NCAN	1.60e-05	8	232	3	24618891
Pubmed	Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.	ABCA7 CR1 EPHA1	1.60e-05	8	232	3	21460840
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CARMIL3 TNRC6B RCC2 CDAN1 CLPB MCF2L HSPA4 PRRC2A KALRN UBR4 TBC1D10B FAM193A INPP5J	2.10e-05	475	232	13	31040226
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP SPEG TNRC6B ARHGEF17 KIAA0319 COBL MCF2L BAIAP3 TNRC6C ZNF365 LGI2 SCRIB	2.12e-05	407	232	12	12693553
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DAB2IP MAP1A SPTBN2 ANKS1B PRAG1 GNAS ANK3 KALRN PITPNM1 NCAN	2.14e-05	281	232	10	28706196
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DAB2IP TNRC6B ADGRV1 BAIAP3 ARAP1 FNDC3A TNRC6C SCRIB NIN	2.23e-05	225	232	9	12168954
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TNRC6B CHEK1 WIZ TNRC6A UTRN IRS4 UBR4 WDR26 ARAF FAM193A ZFHX4 ZBTB10	2.75e-05	418	232	12	34709266
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	DAB2IP HIP1 MYO9A ANKS1B ADGRV1 NDUFV1 ACAN AGAP3 ARAF TBC1D10B NCAN PAM	3.62e-05	430	232	12	32581705
Pubmed	Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.	SIGLEC5 SIGLEC14	4.43e-05	2	232	2	24799499
Pubmed	Expression of glucocorticoid receptor and early growth response gene 1 during postnatal development of two inbred strains of mice exposed to early life stress.	NR3C1 EGR1	4.43e-05	2	232	2	20453467
Pubmed	A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.	NCOA2 NR3C1	4.43e-05	2	232	2	17635946
Pubmed	Replication analysis of genetic association of the NCAN-CILP2 region with plasma lipid levels and non-alcoholic fatty liver disease in Asian and Pacific ethnic groups.	CILP2 NCAN	4.43e-05	2	232	2	26758378
Pubmed	Mouse lipin-1 and lipin-2 cooperate to maintain glycerolipid homeostasis in liver and aging cerebellum.	LPIN1 LPIN2	4.43e-05	2	232	2	22908270
Pubmed	The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.	STAP2 CBL	4.43e-05	2	232	2	19401194
Pubmed	The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis.	ADAMTS12 ADAMTS7	4.43e-05	2	232	2	19098927
Pubmed	A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia.	PHF23 NUP98	4.43e-05	2	232	2	17287853
Pubmed	Association of CILP2 and ACE gene polymorphisms with cardiovascular risk factors in Slovak midlife women.	ACE CILP2	4.43e-05	2	232	2	24350279
Pubmed	Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.	GLP1R GNAS	4.43e-05	2	232	2	21771891
Pubmed	Differential Roles of Lipin1 and Lipin2 in the Hepatitis C Virus Replication Cycle.	LPIN1 LPIN2	4.43e-05	2	232	2	31752156
Pubmed	Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.	SIGLEC5 SIGLEC14	4.43e-05	2	232	2	26459514
Pubmed	A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.	NCOA2 NR3C1	4.43e-05	2	232	2	15769988
Pubmed	Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.	PHF23 NUP98	4.43e-05	2	232	2	32620764
Pubmed	Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.	NCOA2 NR3C1	4.43e-05	2	232	2	23132854
Pubmed	The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids.	NR3C1 EGR1	4.43e-05	2	232	2	15834420
Pubmed	Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.	SIGLEC9 MUC16	4.43e-05	2	232	2	20497550
Pubmed	Quantitative trait loci for body weight in the intercross between SM/J and A/J mice.	NR3C1 EGR1	4.43e-05	2	232	2	11515095
Pubmed	Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.	PAPLN IFNLR1	4.43e-05	2	232	2	19724244
Pubmed	A novel mutation of the hGR gene causing Chrousos syndrome.	NCOA2 NR3C1	4.43e-05	2	232	2	26031419
Pubmed	A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2.	LPIN1 LPIN2	4.43e-05	2	232	2	19717560
Pubmed	Role of GW182 protein in the cell.	TNRC6B TNRC6A	4.43e-05	2	232	2	29791863
Pubmed	Glomerular-specific imprinting of the mouse gsalpha gene: how does this relate to hormone resistance in albright hereditary osteodystrophy?	GNAS UTRN	4.43e-05	2	232	2	8812454
Pubmed	G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency.	STK36 GNAS	4.43e-05	2	232	2	19158402
Pubmed	ABCA7 and EphA1 Genes Polymorphisms in Late-Onset Alzheimer's Disease.	ABCA7 EPHA1	4.43e-05	2	232	2	31659653
Pubmed	Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells.	LPIN1 LPIN2	4.43e-05	2	232	2	24133206
Pubmed	Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.	FGA EGR1	4.43e-05	2	232	2	21356363
Pubmed	Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes.	NCOA2 NR3C1	4.43e-05	2	232	2	23159735
Pubmed	Genetic susceptibility of common polymorphisms in NIN and SIGLEC5 to chronic periodontitis.	SIGLEC5 NIN	4.43e-05	2	232	2	30765789
Pubmed	The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism.	NR3C1 NR2F2	4.43e-05	2	232	2	14739255
Pubmed	Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration.	LPIN1 LPIN2	4.43e-05	2	232	2	29534981
Pubmed	Haploinsufficiency of Lipin3 leads to hypertriglyceridemia and obesity by disrupting the expression and nucleocytoplasmic localization of Lipin1.	LPIN1 LPIN3	4.43e-05	2	232	2	37776435
Pubmed	Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells.	DAB2IP EGR1	4.43e-05	2	232	2	27834104
Pubmed	The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities.	LPIN1 LPIN2	4.43e-05	2	232	2	2722772
Pubmed	Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.	NCOA2 NR3C1	4.43e-05	2	232	2	12151000
Pubmed	The phosphatidic acid-binding, polybasic domain is responsible for the differences in the phosphoregulation of lipins 1 and 3.	LPIN1 LPIN3	4.43e-05	2	232	2	28982975
Pubmed	Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.	DAB2IP ESR2	4.43e-05	2	232	2	26587829
Pubmed	Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation.	ADAMTS12 ADAMTS7	4.43e-05	2	232	2	22247065
Pubmed	Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.	ABCA7 CR1 EPHA1	4.65e-05	11	232	3	21460841
Pubmed	Selective Response to Bacterial Infection by Regulating Siglec-E Expression.	SIGLEC9 SIGLEC5 SIGLEC14	4.65e-05	11	232	3	32889432
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SPTBN2 MBD1 RIPPLY3 ANKS1B APBB3 NCKAP5 TTC3 FAM53C WIZ CLPB OLFM1 UTRN PRRC2A AGAP3 NCOA2 ANK3 KALRN UBR4 WDR26 ZNF365 WDR59 SCRIB	5.60e-05	1285	232	22	35914814
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	PDLIM7 SAV1 TNRC6B CLPB TNRC6A TNRC6C CBL CEP164 FAM193A CSPP1	6.74e-05	322	232	10	39098523
Pubmed	CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.	SIGLEC9 SIGLEC5 SIGLEC14	7.98e-05	13	232	3	35921817
Pubmed	A two-dimensional electrophoresis reference map of human ovary.	HSPA4 EMILIN1 LGI2	7.98e-05	13	232	3	16021519
Pubmed	Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.	ESR2 NCOA2 NR3C1	7.98e-05	13	232	3	11266503
Pubmed	Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation.	TNRC6B TNRC6A TNRC6C	1.01e-04	14	232	3	19716330
Pubmed	GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets.	TNRC6B TNRC6A TNRC6C	1.26e-04	15	232	3	21981923
Pubmed	Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	11579105
Pubmed	Very large G protein-coupled receptor 1 regulates myelin-associated glycoprotein via Gαs/Gαq-mediated protein kinases A/C.	ADGRV1 GNAS	1.32e-04	3	232	2	24191038
Pubmed	ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.	ESR2 CBL	1.32e-04	3	232	2	23158001
Pubmed	Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	30577572
Pubmed	A novel Siglec-F+ neutrophil subset in the mouse nasal mucosa exhibits an activated phenotype and is increased in an allergic rhinitis model.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	32247614
Pubmed	Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.	SIGLEC9 SIGLEC5	1.32e-04	3	232	2	16828866
Pubmed	Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.	ESR2 FOXO3	1.32e-04	3	232	2	18312651
Pubmed	Kalirin, a cytosolic protein with spectrin-like and GDP/GTP exchange factor-like domains that interacts with peptidylglycine alpha-amidating monooxygenase, an integral membrane peptide-processing enzyme.	KALRN PAM	1.32e-04	3	232	2	9139723
Pubmed	Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1.	NCOA2 NR3C1	1.32e-04	3	232	2	15557560
Pubmed	The WTX/AMER1 gene family: evolution, signature and function.	AMER2 AMER3	1.32e-04	3	232	2	20843316
Pubmed	Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	24698729
Pubmed	The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.	NUTM2A NUTM2B	1.32e-04	3	232	2	22456610
Pubmed	Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.	ESR2 FOXO3	1.32e-04	3	232	2	24077289
Pubmed	Analyses of Sequence Variants in the MYOC Gene and of Single Nucleotide Polymorphisms in the NR3C1 and FKBP5 Genes in Corticosteroid-Induced Ocular Hypertension.	MYOC NR3C1	1.32e-04	3	232	2	24417561
Pubmed	Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	17012248
Pubmed	Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells.	NCOA2 NR3C1	1.32e-04	3	232	2	19805480
Pubmed	Siglec-F is induced by granulocyte-macrophage colony-stimulating factor and enhances interleukin-4-induced expression of arginase-1 in mouse macrophages.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	31520477
Pubmed	Antiallergic effect of anti-Siglec-F through reduction of eosinophilic inflammation in murine allergic rhinitis.	SIGLEC5 SIGLEC14	1.32e-04	3	232	2	23710953
Interaction	YWHAH interactions	DAB2IP CDK17 MYO9A SPEG ESR2 DHX38 SAV1 CHEK1 ARHGEF17 PRAG1 FAM53C GRID2IP COBL HERC1 PPIP5K2 DMWD UTRN HSPA4 AGAP3 NCOA2 FOXO3 IRS4 KIF26B TNS2 NR3C1 CBL WDR26 EML3 ARAF LPIN3 TBC1D10B SCRIB PLCH1 CSPP1 ZRANB1 NIN	9.09e-09	1102	228	36	int:YWHAH
Interaction	TOP3B interactions	DAB2IP STK36 HIP1 SPEG SPTBN2 APBB3 TNRC6B DGKQ TTC3 DYSF PRAG1 ABCA7 WIZ COBL GNAS HERC1 MCF2L DMWD BRAT1 MYRF PRRC2A ARAP1 AGAP3 FOXO3 DPH2 KALRN UBR4 PAPLN TNRC6C EML3 WDR59 NR2F2 IFNLR1 LPIN3 POMGNT2 ADAMTS7 LTK PRRT4 TOP3A	5.12e-07	1470	228	39	int:TOP3B
Interaction	YWHAG interactions	DAB2IP CDK17 MYO9A SPEG ESR2 MBD1 CHEK1 ARHGEF17 PRAG1 FAM53C LPIN1 GRID2IP COBL GNAS PPIP5K2 DMWD UTRN HSPA4 AGAP3 FOXO3 IRS4 LNX2 KIF26B TNS2 CBL EML3 ARAF LPIN3 TBC1D10B SCRIB PLCH1 CSPP1 ZRANB1 PPP6R3 PSD4	6.04e-07	1248	228	35	int:YWHAG
Cytoband	Ensembl 112 genes in cytogenetic band chr11q13	SPTBN2 ARHGEF17 CCDC88B NDUFV1 CLPB C11orf68 CDC42EP2 ARAP1 PITPNM1 PPP6R3	1.18e-04	454	232	10	chr11q13
GeneFamily	Lipins	LPIN1 LPIN3 LPIN2	5.27e-07	3	147	3	1043
GeneFamily	Fibronectin type III domain containing	IGFN1 PTPRH PTPRJ ROBO3 KALRN FNDC3A TNXB EPHA1 EPHA7	6.45e-06	160	147	9	555
GeneFamily	Sterile alpha motif domain containing	ANKS1B KIF24 DDHD2 ARAP1 EPHA1 EPHA7	8.17e-05	88	147	6	760
GeneFamily	PDZ domain containing	IL16 PDLIM7 SYNPO2L GRID2IP LNX2 APBA3 SCRIB	2.46e-04	152	147	7	1220
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 SPEG MDGA2 HMCN2 ROBO3 KALRN PAPLN	3.50e-04	161	147	7	593
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN NCAN	3.90e-04	4	147	2	574
GeneFamily	Proline rich transmembrane proteins	PRRT3 PRRT4	3.90e-04	4	147	2	688
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6B TNRC6A TNRC6C	1.06e-03	25	147	3	775
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN C4BPA CR1 NCAN	1.19e-03	57	147	4	1179
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN2 SPTBN5	1.34e-03	7	147	2	1113
GeneFamily	CD molecules\|C2-set domain containing\|Sialic acid binding Ig like lectins	SIGLEC9 SIGLEC5 SIGLEC14	1.49e-03	28	147	3	745
GeneFamily	Adenosine receptors\|V-set domain containing	SIGLEC9 SIGLEC5 ACAN SLAMF9 SIGLEC14 NCAN	2.18e-03	163	147	6	590
GeneFamily	Ankyrin repeat domain containing	ANKS1B TRANK1 CLPB ANKIB1 ARAP1 AGAP3 ANK3	3.68e-03	242	147	7	403
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHA1 EPHA7	5.60e-03	14	147	2	1095
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GABRB2 IGFN1 SPEG NUTM2A ANKS1B MDGA2 TTC3 LPIN1 AMER2 AJAP1 TNRC6A ANKIB1 OLFM1 HERC1 MCF2L ANK3 RGS7BP BRSK2 AMER3 TNRC6C INSYN2A ZFHX4 LGI2 CSPG5 NCAN PRRT4	5.65e-06	1106	231	26	M39071
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	STK36 MBD1 APBB3 DGKQ DENND1C DYSF NDUFV1 LPIN1 CDAN1 BRAT1 UTRN POFUT2 NBPF3 ZC3H12A UBR4 EML3 WDR59 ARAF PITPNM1 CD1C YJU2 C11orf21 TOP3A	5.82e-06	905	231	23	M40865
Coexpression	PEREZ_TP53_TARGETS	DAB2IP ADGRV1 ARHGEF17 ABCA7 PTPRJ UMODL1 PRRT3 GNAS EME2 MCF2L HILPDA MYRF BAIAP3 ARAP1 AGAP3 MDFIC ANK3 KALRN KIF26B TNRC6C CEP164 INSYN2A ADAMTS7 EGR1 KNDC1 TSPYL5 GAA	8.30e-06	1201	231	27	M4391
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	GABRB2 SPEG ANKS1B MDGA2 LPIN1 AMER2 AJAP1 ANKIB1 HERC1 ANK3 RGS7BP KALRN AMER3 ZFHX4 NCAN	1.80e-05	465	231	15	M39066
Coexpression	NABA_CORE_MATRISOME	CILP2 HMCN2 ACAN FGA C4BPA IMPG2 PAPLN EMILIN1 LGI2 NCAN TNXB	3.02e-05	270	231	11	MM17057
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 STK36 IGFN1 MDGA2 ADGRV1 TRANK1 DISP3 ZAN DNAH10 KALRN KIF26B ZFHX4 PLCH1 EPHA7	1.03e-12	184	232	14	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 STK36 IGFN1 MDGA2 ADGRV1 TRANK1 DISP3 ZAN DNAH10 KALRN KIF26B ZFHX4 PLCH1 EPHA7	1.03e-12	184	232	14	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 STK36 IGFN1 MDGA2 ADGRV1 TRANK1 DISP3 ZAN DNAH10 KALRN KIF26B ZFHX4 PLCH1 EPHA7	1.03e-12	184	232	14	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	PDLIM7 SYNPO2L CDC42EP2 ROBO3 TNS2 EMILIN1 NR2F2 ADAMTS12 TNXB	1.60e-07	159	232	9	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG MDGA2 ARHGEF17 NFATC4 GNAS GPAT2 KALRN BRSK2 LGI2	2.83e-07	170	232	9	cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG MDGA2 ARHGEF17 NFATC4 GNAS GPAT2 KALRN BRSK2 LGI2	2.83e-07	170	232	9	99dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG MDGA2 ARHGEF17 NFATC4 GNAS GPAT2 KALRN BRSK2 LGI2	2.83e-07	170	232	9	3a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAM110D RIPPLY3 DYSF RASIP1 CDC42EP2 MCF2L ZC3H12A ZAN PRRT4	3.28e-07	173	232	9	ad9777e4ae70b11676ec735eb6db91776ca0cb19
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM110D RIPPLY3 CHEK1 ACE RASIP1 GLP1R MCF2L HILPDA STAP2	3.80e-07	176	232	9	269326c2bf44a9003d95bc6dbc839f08f25737ca
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKS1B SIGLEC5 MDGA2 AJAP1 ANK3 BCAS1 LRRC52 CSPG5 OTOP1	5.03e-07	182	232	9	82ca6d5ed48b4c487ce00b9309255abb8f20b61d
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	SSC5D ZNF469 CILP2 HMCN2 ACAN P3H3 KIF26B EMILIN1 ADAMTS12	5.52e-07	184	232	9	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	HIP1 ARHGEF17 GPAT2 UTRN KALRN RGL3 EMILIN1 NR2F2 ADAMTS12	6.04e-07	186	232	9	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	HIP1 ARHGEF17 GPAT2 UTRN KALRN RGL3 EMILIN1 NR2F2 ADAMTS12	6.32e-07	187	232	9	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2IP FAM110D RIPPLY3 DYSF RASIP1 CDC42EP2 MCF2L UTRN STAP2	7.54e-07	191	232	9	79b399496bd7322a1d53c43378f48695fd09a5d9
ToppCell	facs-Trachea-24m-Endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2IP FAM110D RIPPLY3 DYSF RASIP1 CDC42EP2 MCF2L UTRN STAP2	7.54e-07	191	232	9	9c6d5d045781c6506ae80e318427ef1e0d87f45c
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2IP FAM110D RIPPLY3 DYSF RASIP1 CDC42EP2 MCF2L UTRN STAP2	7.54e-07	191	232	9	1b1e943709d0c3283a980c7c965ef1f110506a29
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A IL22RA1 ACAN CDC42EP2 MYRF ADAMTS12 KNDC1 SCRIB	8.21e-07	142	232	8	67d4ff3483ae34f77c3325aa0fbd3462ca19ade4
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF17 ROBO3 GPAT2 AGAP3 ENTHD1 LGI2 GPR156 LTK	1.01e-06	146	232	8	2ac9b487a7991fdc15444aeb93533030e09825bb
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO9A EPS8L1 ADGRV1 COBL MYRF UTRN LMNTD2 PKP3 LPIN2	1.11e-06	200	232	9	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PDLIM7 SPEG KIF24 C4BPA BAIAP3 KIAA1614 CEP164 PRF1	1.12e-06	148	232	8	065177aaa63c0441d312260b43ecdac78c84ad03
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A IL22RA1 ACAN CDC42EP2 MYRF ADAMTS12 KNDC1 SCRIB	1.24e-06	150	232	8	afd651c654e715414eff64cf3a37378d057a56a2
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	IL16 FAM110D MDGA2 DYSF RASIP1 GNAS RGS7BP STAP2	2.32e-06	163	232	8	c21114826bee1b05b411984326fef6b6e0d05316
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	IL16 FAM110D MDGA2 DYSF RASIP1 GNAS RGS7BP STAP2	2.32e-06	163	232	8	5d49414432db259a19df50d7944581d00b69f537
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	PDLIM7 ZNF469 CILP2 HMCN2 ACAN KIF26B FAM53A LGI2	2.42e-06	164	232	8	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	GABRB2 SPTBN2 MYRF KLK11 BCL2L10 MUC16 KLK8 GPR156	2.65e-06	166	232	8	4d63c758d46e73311b864148c646bf081498dee7
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	GABRB2 SPTBN2 MYRF KLK11 BCL2L10 MUC16 KLK8 GPR156	2.65e-06	166	232	8	4160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	DAB2IP PDLIM7 SPEG HMCN2 ROBO3 KALRN P3H3 EGR1	2.77e-06	167	232	8	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPTBN2 MYRF KLK11 BCL2L10 MUC16 PKP3 KLK8 KNDC1	2.90e-06	168	232	8	e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPTBN2 MYRF KLK11 BCL2L10 MUC16 PKP3 KLK8 KNDC1	2.90e-06	168	232	8	403aba73a0f9ffb32252288d075fad8a588ca440
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	IGFN1 MAP1A PDLIM7 HMCN2 CDC42EP2 EMILIN1 ZFHX4 TNXB	2.90e-06	168	232	8	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ESR2 NCKAP5 ADGRV1 ACAN C4BPA ANK3 EGR1 LPIN2	3.17e-06	170	232	8	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SSC5D EMILIN1 NR2F2 ADAMTS12 ZFHX4 DIXDC1 TNXB EPHA7	4.64e-06	179	232	8	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKS1B MDGA2 AJAP1 ANK3 BCAS1 LRRC52 CSPG5 OTOP1	5.24e-06	182	232	8	e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKS1B MDGA2 AJAP1 ANK3 BCAS1 LRRC52 CSPG5 OTOP1	5.24e-06	182	232	8	d568a8aec7e27ce632e248baea2ccd0e8dd255ac
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	HIP1 PDLIM7 SPEG ANKS1B HMCN2 RGS7BP KALRN LGI2	5.46e-06	183	232	8	818fd886e0188091310825f9145fa53328f2c979
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	HIP1 ARHGEF17 GPAT2 UTRN KALRN RGL3 NR2F2 ADAMTS12	5.46e-06	183	232	8	273db6a3b00a93ca852498471187b642b5368185
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	HIP1 ARHGEF17 GPAT2 UTRN KALRN RGL3 NR2F2 ADAMTS12	5.46e-06	183	232	8	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	HIP1 PDLIM7 ANKS1B HMCN2 RGS7BP KALRN RGL3 LGI2	5.46e-06	183	232	8	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 MDGA2 ARHGEF17 NFATC4 UTRN RGS7BP TNS2 NR2F2	5.91e-06	185	232	8	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D CILP2 P3H3 KIF26B PAPLN EMILIN1 ADAMTS12 LGI2	5.91e-06	185	232	8	87c416d14ca6255bee39b16e7571553e36ee3069
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	HIP1 ARHGEF17 GPAT2 UTRN KALRN RGL3 NR2F2 ADAMTS12	5.91e-06	185	232	8	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 MDGA2 ARHGEF17 NFATC4 UTRN RGS7BP TNS2 NR2F2	5.91e-06	185	232	8	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	HIP1 ARHGEF17 GPAT2 UTRN KALRN RGL3 NR2F2 ADAMTS12	5.91e-06	185	232	8	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ADGRV1 COBL MCF2L BCAS1 SIM1 LGI2 EPHA7	6.39e-06	187	232	8	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	IGFN1 FAM110D PRAG1 SSC5D CILP2 HMCN2 PAPLN CD1C	6.65e-06	188	232	8	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP CDK17 FAM110D RIPPLY3 DYSF RASIP1 MCF2L KLK8	6.65e-06	188	232	8	e5a8ca4613ab0bf1584b9e78959adf41d0bf379f
ToppCell	facs-Heart-LV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP CDK17 FAM110D RIPPLY3 DYSF RASIP1 MCF2L KLK8	6.65e-06	188	232	8	0fc3a6562e6895f6fe7a93397eae842a75c60c93
ToppCell	facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP CDK17 FAM110D RIPPLY3 DYSF RASIP1 MCF2L KLK8	6.65e-06	188	232	8	ed11e26ff4ef3d6314b5f5734062519b9aa285c1
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ADAM20 SSC5D KLK11 GALR3 SIGLEC14 GPR61	6.71e-06	88	232	6	1ca0e16981e88030987412e12838a9797b97b9c9
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HIP1 FAM110D RIPPLY3 DYSF RASIP1 CDC42EP2 MCF2L STAP2	7.18e-06	190	232	8	632d5dc11765053366d61f0a0c7916111cea4f50
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 SPEG ARHGEF17 ACAN RGS7BP KALRN NR2F2 ADAMTS12	7.18e-06	190	232	8	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CDK17 HIP1 ARHGEF17 MCF2L GPAT2 UTRN NR2F2 ADAMTS12	7.18e-06	190	232	8	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 PRAG1 COBL MYRF LNX2 ANK3 RGL3 PLCH1	7.47e-06	191	232	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	droplet-Lung-3m-Endothelial-capillary_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAM110D RIPPLY3 NCKAP5 ACE RASIP1 MCF2L HILPDA STAP2	8.06e-06	193	232	8	1b6317b740cad2439f08b9e9895426d861e7a161
ToppCell	droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAM110D RIPPLY3 NCKAP5 ACE RASIP1 MCF2L HILPDA STAP2	8.06e-06	193	232	8	f5861cfa4401b476229a7c61cd64abad79a4bbfc
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ABCA7 HERC1 FOXO3 LNX2 CR1 WDR26 LPIN2 C11orf21	8.06e-06	193	232	8	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A IL22RA1 ACAN CDC42EP2 ADAMTS12 KNDC1 SCRIB	8.09e-06	138	232	7	c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13
ToppCell	metastatic_Brain-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	SIGLEC9 RIPPLY3 NUTM2B P3H3 FAM53A GZMK SCRIB	8.09e-06	138	232	7	b2ab273f3e62f169b3b9cb82342e6617af99f582
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 ANK3 UBR4 STAP2 PAPLN LPIN2 DIXDC1 EPHA7	8.37e-06	194	232	8	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	facs-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNRC6B UTRN ARAP1 P3H3 EMILIN1 NR2F2 EGR1 PAM	9.01e-06	196	232	8	c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCell	facs-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNRC6B UTRN ARAP1 P3H3 EMILIN1 NR2F2 EGR1 PAM	9.01e-06	196	232	8	44f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A ANKS1B AMER2 CDC42EP2 MYRF GPAT2 ANK3 DIXDC1	9.01e-06	196	232	8	37a5f9f3988778655580bd0383811bb4930c1551
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 SPEG ARHGEF17 ACAN UTRN BRSK2 EMILIN1 LGI2	9.36e-06	197	232	8	02e70768a917c5f097bc653e9e965a1000289d2e
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 SPEG ARHGEF17 ACAN UTRN BRSK2 EMILIN1 LGI2	9.36e-06	197	232	8	8b3bf5b45e49bf1c60e4d2703b470bb890385f67
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO9A EPS8L1 ADGRV1 COBL UTRN ANK3 LMNTD2 LPIN2	9.36e-06	197	232	8	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 ANKS1B MDGA2 TTC3 OLFM1 HERC1 ANK3 KALRN	9.71e-06	198	232	8	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDLIM7 ANKS1B SSC5D NR2F2 ZFHX4 DIXDC1 TNXB EPHA7	1.01e-05	199	232	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TNRC6B PTPRJ TNRC6A HERC1 UTRN NCOA2 ANK3 PPP6R3	1.01e-05	199	232	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DYSF ACE RASIP1 AMER2 AJAP1 KALRN ITPRIP LTK	1.04e-05	200	232	8	105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	ANKS1B SSC5D NR2F2 ADAMTS12 ZFHX4 DIXDC1 TNXB EPHA7	1.04e-05	200	232	8	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A PDLIM7 ANKS1B SSC5D NR2F2 ZFHX4 DIXDC1 TNXB	1.04e-05	200	232	8	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Glia_progenitor_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	SP100 FAM178B ACAN MYRF BCAS1 CCDC61 ZNF365 ADAMTS12	1.04e-05	200	232	8	6c1b7b0f3cd35d8cfee181ea83c73127dbc41ac5
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A PDLIM7 ARHGEF17 SSC5D ACAN DMWD NR2F2 DIXDC1	1.04e-05	200	232	8	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOC DGKQ CHEK1 DENND1C CILP2 ROBO3 IL25	1.39e-05	150	232	7	47ea08d7609e1d2382bf56ef9e5c767e3597cf93
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ADAM20 SSC5D KLK11 GALR3 GPR61 PRF1	1.40e-05	100	232	6	cb0deaf1c33d2789417e93cc01d94e34a611d20a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DGKQ SSC5D ERP27 LMNTD2 ZNF446 PRF1 GZMK	1.52e-05	152	232	7	669d8f12fdb110ed72f4e5348b7b5350144a061c
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB3 ADGRV1 PRAG1 OLFM1 TECPR1 MDFIC PRF1	1.72e-05	155	232	7	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB3 ADGRV1 PRAG1 OLFM1 TECPR1 MDFIC PRF1	1.72e-05	155	232	7	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	GABRB2 SPEG ANKS1B MYRF KLK11 MUC16 ZFHX4	1.80e-05	156	232	7	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GPAT2 BAIAP3 UTRN LRRC75B IRS4 EMILIN1 NR2F2	1.87e-05	157	232	7	741d79c10cb87fa7f14080c6fccb1553c3a20bad
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAM20 SPTBN2 MYRF BRSK2 CCDC61 DNLZ PKP3	1.95e-05	158	232	7	2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHEK1 FAM53C KIF24 HSPA4 LRRC52 GAA IL9R	2.03e-05	159	232	7	f7bccfeffa737f151417bf52ea45111b0957bce9
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	HIP1 PDLIM7 HMCN2 UTRN RGS7BP KALRN NR2F2	2.20e-05	161	232	7	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRB2 ANKS1B MYRF KLK11 MUC16 ZFHX4 KNDC1	2.48e-05	164	232	7	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	GABRB2 SYNPO2L PRR25 ANK3 AMER3 GPR61 PRRT4	2.58e-05	165	232	7	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	severe-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MAP1A AJAP1 COBL PAPLN INSYN2A IFNLR1 LTK	2.68e-05	166	232	7	ae38850fde549b8dd6fb12f0ef80b428ade50485
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESR2 EPS8L1 TECPR1 LRRC75B ANK3 KALRN GPR156	2.68e-05	166	232	7	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESR2 EPS8L1 TECPR1 LRRC75B ANK3 KALRN GPR156	2.68e-05	166	232	7	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SPTBN2 DISP3 WDR59 LGI2 LTK PLCH1 INPP5J	2.78e-05	167	232	7	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SPTBN2 DISP3 WDR59 LGI2 LTK PLCH1 INPP5J	2.78e-05	167	232	7	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 GPAT2 LRRC75B UBOX5 EMILIN1 ARAF SCRIB	2.89e-05	168	232	7	8459d0a1bf6d4b5c83001097331f8b78fceb9305
ToppCell	Control\|World / group, cell type (main and fine annotations)	ANKS1B NCKAP5 ADGRV1 COBL ANK3 EGR1 PLCH1	2.89e-05	168	232	7	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NFATC4 PLA2R1 PKP3 EPHA1 IL9R	3.00e-05	69	232	5	cdd42abdd072aa438830d837ee857529269a81e0
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NFATC4 PLA2R1 PKP3 EPHA1 IL9R	3.00e-05	69	232	5	a157b1582401cebd222343d94086dbea876140c2
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DENND1C LPIN1 USP51 BAIAP3 PKP3 GZMK KLK8	3.12e-05	170	232	7	d74fbd995a8a37fc237f7147d398357b811d6452
ToppCell	COVID-19_Convalescent-cDC\|COVID-19_Convalescent / Disease condition and Cell class	HIP1 RCC2 BRAT1 DNAH10 PAPLN CD1C PRF1	3.24e-05	171	232	7	9ccaa9f1629818b0f63a5d930ee78c01e04cd98d
ToppCell	COVID-19_Convalescent-cDC-\|COVID-19_Convalescent / Disease condition and Cell class	HIP1 RCC2 BRAT1 DNAH10 PAPLN CD1C PRF1	3.24e-05	171	232	7	fb5fae8b3adafcbb7c5618d887966b418355ed4d
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	HIP1 PDLIM7 ACAN UTRN RGS7BP KALRN RGL3	3.24e-05	171	232	7	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 ACAN UTRN RGS7BP BRSK2 EMILIN1 LGI2	3.49e-05	173	232	7	901b8e6909c1f3849906fad9cee17b8f0bab050d
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 ACAN UTRN RGS7BP BRSK2 EMILIN1 LGI2	3.49e-05	173	232	7	fc2602b2ce051cd4c33957d7e3d041ff8a529883
Drug	Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; HL60; HT_HG-U133A	CDK17 GLP1R GNAS IMPG2 ANK3 KALRN TNS2 CEP164 ADAMTS7 GZMK PLCH1 GAA INPP5J	1.15e-07	198	229	13	2552_UP
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A	HIP1 PDLIM7 ARHGEF17 WIZ ARAP1 CR1 EML3 CEP164 ZFHX4 PRF1 TOP3A EPHA1	7.12e-07	195	229	12	4971_UP
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HT_HG-U133A	SPTBN2 EPS8L1 GLP1R RHBDD3 BAIAP3 P3H3 BCAS1 HHLA1 ADAMTS12 EGR1 TOP3A INPP5J	7.52e-07	196	229	12	4465_DN
Drug	Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A	DGKQ RASIP1 GLP1R MLN OLFM1 RHBDD3 C4BPA ARAP1 IRS4 KALRN BCAS1 EGR1	7.52e-07	196	229	12	3763_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A	PDLIM7 EPS8L1 CLPB GLP1R HILPDA MYRF HSPA4 BCAS1 UBOX5 EML3 NR2F2 EGR1	7.94e-07	197	229	12	1327_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A	GABRB2 IL16 ACE AJAP1 PTPRH ACAN OLFM1 COBL C4BPA IMPG2 CR1 C11orf21	8.37e-07	198	229	12	3756_UP
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A	SP100 PDLIM7 SAV1 DYSF WIZ AJAP1 MYRF BAIAP3 ZC3H12A BCL2L10 PRF1 LPIN2	8.37e-07	198	229	12	7024_UP
Drug	Iohexol [66108-95-0]; Down 200; 4.8uM; MCF7; HT_HG-U133A	SP100 WIZ GLP1R RHBDD3 NCOA2 ANK3 FNDC3A CEP164 PKP3 C11orf21 TOP3A	4.38e-06	193	229	11	3322_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A	HIP1 PDLIM7 EPS8L1 DYSF ARHGEF17 GLP1R RHBDD3 ARAP1 PITPNM1 PKP3 PSD4	4.60e-06	194	229	11	3604_DN
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A	PDLIM7 SPTBN2 ACAN GLP1R RHBDD3 DMWD SIM1 NR3C1 EML3 PITPNM1 EPHA1	4.60e-06	194	229	11	7347_UP
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	HIP1 ESR2 ABCA7 SPTBN5 GLP1R UBOX5 EGR1 GZMK PLCH1 EPHA1 PSD4	4.83e-06	195	229	11	4792_UP
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A	IL16 ADAM20 SPEG BCL2L10 GALR3 NR3C1 CR1 ZFHX4 EGR1 C11orf21 PLCH1	5.07e-06	196	229	11	6416_UP
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CDC42EP2 RHBDD3 GNAS BCL2L10 KIF26B UBOX5 ZNF365 EGR1 LPIN2 PLCH1 TOP3A	5.07e-06	196	229	11	6260_UP
Drug	Calciferol [50-14-6]; Up 200; 10uM; HL60; HT_HG-U133A	GABRB2 SIGLEC9 EPS8L1 ACAN GLP1R POFUT2 WDR59 ZNF446 ADAMTS7 NCAN TOP3A	5.07e-06	196	229	11	2442_UP
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SP100 SPTBN2 DENND1C DYSF GLP1R GNAS BAIAP3 IRS4 BCL2L10 UBOX5 CD1C	5.33e-06	197	229	11	7217_UP
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A	CDK17 MYOC WIZ ARAP1 IRS4 NR3C1 CR1 ADAMTS12 ADAMTS7 PRF1 GZMK	5.33e-06	197	229	11	3355_UP
Drug	Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A	MAP1A ACAN GLP1R GNAS MYRF BAIAP3 ARAP1 GALR3 APBA3 PRF1 INPP5J	5.59e-06	198	229	11	4947_UP
Drug	5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA	MBD1 CDC42EP2 NCOA2 ANK3 FNDC3A EML3 WDR59 CEP164 PITPNM1 EGR1 CSPP1	5.59e-06	198	229	11	908_UP
Drug	Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; PC3; HT_HG-U133A	GABRB2 HIP1 IL22RA1 ACAN COBL C4BPA MCF2L IMPG2 KALRN EGR1 PSD4	5.59e-06	198	229	11	6611_UP
Drug	Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A	HIP1 ESR2 SPTBN2 ARHGEF17 IL22RA1 SPTBN5 MLN MCF2L GALR3 FNDC3A TOP3A	5.59e-06	198	229	11	4273_UP
Drug	Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	EPS8L1 ARHGEF17 LPIN1 GLP1R CDC42EP2 MCF2L NCOA2 ZNF446 PITPNM1 PIK3R5 EPHA1	6.15e-06	200	229	11	7463_UP
Drug	Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A	ADAM20 CDC42EP2 BAIAP3 NCOA2 IRS4 BCL2L10 NUP98 UBOX5 CEP164 EGR1 LPIN2	6.15e-06	200	229	11	5487_UP
Drug	Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A	DGKQ ARHGEF17 LPIN1 C4BPA ARAP1 ADAMTS12 PLA2R1 CD1C EGR1 PAM	2.61e-05	192	229	10	4129_UP
Drug	15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	SPTBN2 DYSF GNAS NCOA2 MUC16 FNDC3A NR3C1 GZMK PIK3R5 PSD4	2.61e-05	192	229	10	7489_UP
Drug	rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A	MAP1A PDLIM7 TRANK1 MLN ZC3H12A UBR4 FNDC3A CR1 EGR1 TOP3A	2.61e-05	192	229	10	1174_UP
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA	SP100 MAP1A MBD1 EPS8L1 WIZ GLP1R ARAP1 NCOA2 APBA3 UBOX5	2.73e-05	193	229	10	881_UP
Drug	Theobromine [83-67-0]; Down 200; 22.2uM; PC3; HT_HG-U133A	HIP1 PDLIM7 MBD1 WIZ GLP1R RHBDD3 MYRF CEP164 NR2F2 EPHA1	2.73e-05	193	229	10	6613_DN
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	SP100 ARHGEF17 RHBDD3 BAIAP3 ARAP1 ZC3H12A APBA3 CEP164 DIXDC1 EPHA1	2.86e-05	194	229	10	5362_UP
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	LPIN1 COBL C4BPA MDFIC NUP98 FNDC3A CBL EMILIN1 PRF1 GZMK	2.86e-05	194	229	10	4642_UP
Drug	Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A	MYOC DGKQ SPTBN5 ACAN OLFM1 MCF2L IMPG2 KALRN CR1 GZMK	2.86e-05	194	229	10	3812_UP
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PDLIM7 ESR2 WIZ UTRN IRS4 TNS2 NR3C1 CR1 C11orf21 PSD4	2.98e-05	195	229	10	2813_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A	MYOC ARHGEF17 WIZ NFATC4 ROBO3 ARAP1 NR3C1 HHLA1 C11orf21 PIK3R5	2.98e-05	195	229	10	3378_UP
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A	PDLIM7 EPS8L1 DYSF WIZ RHBDD3 MCF2L POFUT2 ARAP1 NCOA2 YJU2	3.12e-05	196	229	10	4779_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	HIP1 CHEK1 GNAS UTRN HSPA4 PRRC2A NCOA2 ANK3 FNDC3A EGR1	3.26e-05	197	229	10	2128_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A	GABRB2 EPS8L1 ARHGEF17 UTRN IMPG2 NR3C1 ZNF446 CEP164 INPP5J PSD4	3.26e-05	197	229	10	6106_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A	IL16 HIP1 ADAM20 MYOC ARHGEF17 NFATC4 GLP1R BCL2L10 WDR59 PIK3R5	3.26e-05	197	229	10	3672_UP
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A	ARHGEF17 MYRF IRS4 NR3C1 CBL PRF1 GZMK DIXDC1 PLCH1 TOP3A	3.26e-05	197	229	10	3832_UP
Drug	sulindac sulfone; Up 200; 50uM; MCF7; HG-U133A	SP100 SPEG ESR2 SPTBN2 WIZ DMWD BAIAP3 NCOA2 CBL DIXDC1	3.26e-05	197	229	10	314_UP
Drug	Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A	SP100 DENND1C SPTBN5 AJAP1 FGA GNAS UTRN ARAP1 CD1C GZMK	3.26e-05	197	229	10	6514_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; HL60; HT_HG-U133A	PDLIM7 ESR2 EPS8L1 ACAN RHBDD3 C4BPA DMWD MDFIC ANK3 EGR1	3.26e-05	197	229	10	2374_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	CDK17 MBD1 TNRC6B ZNF324 RHBDD3 NCOA2 NUP98 EML3 ZNF446 CEP164	3.26e-05	197	229	10	2643_DN
Drug	Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A	EPS8L1 MCF2L BAIAP3 MDFIC P3H3 UBOX5 ADAMTS7 C11orf21 LTK PSD4	3.26e-05	197	229	10	5082_UP
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A	HIP1 PDLIM7 WIZ POFUT2 NCOA2 FNDC3A NR3C1 CBL WDR59 PRF1	3.26e-05	197	229	10	5009_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAP1A PDLIM7 SPTBN2 WIZ GLP1R RHBDD3 ARAP1 WDR59 ZNF446 CEP164	3.26e-05	197	229	10	3940_DN
Drug	Tobramycin [32986-56-4]; Down 200; 8.6uM; HL60; HT_HG-U133A	IL16 PDLIM7 UTRN NCOA2 ZC3H12A CR1 UBOX5 NR2F2 PIK3R5 PSD4	3.26e-05	197	229	10	2481_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A	SP100 PDLIM7 EPS8L1 LPIN1 ZNF324 GNAS UTRN NUP98 EML3 DIXDC1	3.26e-05	197	229	10	7293_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	MAP1A PDLIM7 ARHGEF17 WIZ DMWD NCOA2 BCL2L10 CR1 ZNF446 EGR1	3.40e-05	198	229	10	1519_UP
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A	ESR2 ARHGEF17 WIZ GLP1R RHBDD3 MCF2L ARAP1 CR1 PLCH1 INPP5J	3.40e-05	198	229	10	5451_DN
Drug	Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A	SPTBN5 AJAP1 ARAP1 IMPG2 IRS4 NR3C1 CEP164 CD1C NCAN PLCH1	3.40e-05	198	229	10	3324_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; HL60; HG-U133A	SIGLEC5 LPIN1 MLN C4BPA TMEM184B POFUT2 ZC3H12A UBOX5 ADAMTS12 GAA	3.40e-05	198	229	10	1412_UP
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	SP100 PDLIM7 EPS8L1 WIZ MCF2L EML3 PITPNM1 PLCH1 TOP3A PSD4	3.40e-05	198	229	10	6016_DN
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	GABRB2 PDLIM7 ARHGEF17 ARAP1 CR1 EML3 WDR59 ZNF446 TOP3A PSD4	3.40e-05	198	229	10	5445_DN
Drug	Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A	GABRB2 MAP1A PDLIM7 ESR2 MBD1 EPS8L1 BRSK2 NR3C1 GZMK PLCH1	3.40e-05	198	229	10	6206_UP
Drug	Esculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A	MAP1A CDC42EP2 ARAP1 NUP98 TNS2 UBOX5 WDR59 PRF1 PKP3 INPP5J	3.55e-05	199	229	10	6499_DN
Drug	Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A	GABRB2 SP100 TNRC6B ABCA7 CDC42EP2 COBL GNAS PITPNM1 PLCH1 EPHA1	3.55e-05	199	229	10	7477_UP
Drug	Karakoline [39089-30-0]; Up 200; 10.6uM; PC3; HT_HG-U133A	MYOC ESR2 TRANK1 MCF2L ANK3 CR1 ADAMTS12 ADAMTS7 EGR1 PKP3	3.55e-05	199	229	10	4297_UP
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	GABRB2 PDLIM7 EPS8L1 ARHGEF17 RHBDD3 APBA3 TNS2 ZNF446 INPP5J PSD4	3.55e-05	199	229	10	5601_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A	SP100 SPEG WIZ RHBDD3 UTRN CEP164 ZFHX4 ADAMTS7 EGR1 CSPP1	3.55e-05	199	229	10	5992_UP
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A	MAP1A GLP1R RHBDD3 BAIAP3 NR3C1 CBL ZFHX4 PRF1 NCAN EPHA1	3.70e-05	200	229	10	7329_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PDLIM7 MYOC SPTBN2 ARHGEF17 GLP1R ARAP1 NR3C1 HHLA1 ADAMTS12 EPHA1	3.70e-05	200	229	10	4975_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; PC3; HT_HG-U133A	SP100 HIP1 EPS8L1 ACE ARHGEF17 MCF2L BAIAP3 P3H3 CEP164 CSPG5	3.70e-05	200	229	10	4598_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CDC42EP2 DMWD HSPA4 ARAP1 NUP98 EML3 ZNF446 CEP164 CSPG5 TOP3A	3.70e-05	200	229	10	2652_DN
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A	PDLIM7 WIZ APBA3 TNS2 UBOX5 EGR1 PKP3 CSPG5 CSPP1 TOP3A	3.70e-05	200	229	10	3442_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SP100 MBD1 LPIN1 GLP1R NCOA2 ANK3 NR3C1 LPIN2 PSD4	9.87e-05	182	229	9	7422_UP
Drug	B-My	MLN OLFM1 GNAS ARAF	1.07e-04	25	229	4	CID000002291
Drug	4-hydroxytestosterone	ESR2 NCOA2 FOXO3 P3H3 NR2F2 EPHA1	1.36e-04	78	229	6	CID000160615
Drug	cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A	MYO9A MYOC EPS8L1 RHBDD3 C4BPA ARAP1 NR3C1 HHLA1 PITPNM1	1.37e-04	190	229	9	612_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	CDK17 PDLIM7 MBD1 EPS8L1 ZNF324 RHBDD3 NR3C1 PLCH1 CSPP1	1.42e-04	191	229	9	2634_DN
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	PDLIM7 WIZ ZNF324 BAIAP3 ARAP1 NCOA2 NUP98 CR1 PSD4	1.42e-04	191	229	9	5456_DN
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	PDLIM7 WIZ ZNF324 UTRN APBA3 FNDC3A WDR59 PKP3 TOP3A	1.48e-04	192	229	9	4496_DN
Drug	Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	MAP1A DYSF ABCA7 LPIN1 POFUT2 DPH2 APBA3 CBL EGR1	1.48e-04	192	229	9	7485_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	GABRB2 PDLIM7 MBD1 SAV1 GNAS POFUT2 NR3C1 UBOX5 EPHA1	1.54e-04	193	229	9	5256_DN
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A	MAP1A ESR2 RIPPLY3 WIZ PTPRJ ACAN C4BPA WDR59 NR2F2	1.54e-04	193	229	9	3021_UP
Drug	Metergoline [17692-51-2]; Down 200; 10uM; MCF7; HT_HG-U133A	GABRB2 SP100 PDLIM7 WIZ ZNF324 WDR59 CEP164 TOP3A EPHA1	1.54e-04	193	229	9	3221_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	PDLIM7 EPS8L1 ABCA7 ACAN CBL WDR59 CEP164 EGR1 PSD4	1.54e-04	193	229	9	3773_DN
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A	HIP1 ESR2 DENND1C ACAN C4BPA MCF2L DMWD C11orf21 INPP5J	1.54e-04	193	229	9	4306_UP
Drug	trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A	EPS8L1 DYSF WIZ NFATC4 C11orf68 CDC42EP2 NCOA2 TNS2 NR2F2	1.54e-04	193	229	9	413_DN
Drug	AC1L1CD2	ESR2 HSPA4 NR3C1	1.56e-04	11	229	3	CID000027021
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	PDLIM7 LPIN1 COBL HSPA4 ANK3 FNDC3A PRF1 PKP3 CSPG5	1.60e-04	194	229	9	6555_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	LPIN1 GNAS NCOA2 CBL WDR59 PITPNM1 PKP3 LPIN2 PSD4	1.60e-04	194	229	9	7538_DN
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; HL60; HT_HG-U133A	SP100 UTRN HSPA4 NCOA2 MDFIC CR1 CBL EML3 LPIN2	1.60e-04	194	229	9	1293_UP
Drug	CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A	MAP1A SAV1 LPIN1 PTPRH ACAN MYRF ADAMTS12 PRF1 PIK3R5	1.60e-04	194	229	9	3906_UP
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	MAP1A PDLIM7 SPEG ABCA7 UTRN ZC3H12A BCL2L10 NR2F2 PLCH1	1.60e-04	194	229	9	4492_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	EPS8L1 WIZ ZNF324 ARAP1 APBA3 EML3 ZNF446 PITPNM1 PRF1	1.60e-04	194	229	9	4804_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	ESR2 AJAP1 BAIAP3 TNS2 FNDC3A CR1 ZNF446 CEP164 PSD4	1.60e-04	194	229	9	5457_DN
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A	SP100 PDLIM7 TNRC6B EPS8L1 RHBDD3 UTRN TNS2 FNDC3A CEP164	1.60e-04	194	229	9	1274_UP
Drug	diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A	PDLIM7 FAM110D DHX38 ACAN BAIAP3 ANK3 CBL YJU2 PSD4	1.66e-04	195	229	9	333_DN
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	SPTBN5 GNAS UTRN ARAP1 KIF26B TNS2 BCAS1 ZFHX4 PIK3R5	1.66e-04	195	229	9	3553_UP
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	MYOC EPS8L1 MCF2L MDFIC P3H3 ZNF446 ADAMTS7 LTK PLCH1	1.66e-04	195	229	9	5979_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	HIP1 ARHGEF17 GLP1R ARAP1 ANK3 FNDC3A ZNF446 PAM PSD4	1.66e-04	195	229	9	1650_UP
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A	GABRB2 ABCA7 WIZ RHBDD3 C4BPA TMEM184B ARAP1 ZC3H12A EPHA1	1.66e-04	195	229	9	1410_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A	SPEG DYSF ROBO3 IRS4 NR3C1 CEP164 ADAMTS7 PIK3R5 PSD4	1.66e-04	195	229	9	5574_UP
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	GABRB2 CDK17 PDLIM7 WIZ GNAS EGR1 PLCH1 INPP5J PSD4	1.66e-04	195	229	9	5427_DN
Drug	Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	CDK17 SPTBN2 MBD1 EPS8L1 AJAP1 DMWD BAIAP3 HHLA1 EPHA1	1.66e-04	195	229	9	4781_UP
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A	SP100 SPTBN2 CDC42EP2 GNAS UTRN NCOA2 CBL EML3 CEP164	1.66e-04	195	229	9	5077_DN
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A	HIP1 SPTBN2 GLP1R BAIAP3 P3H3 TNS2 PITPNM1 PLCH1 PSD4	1.66e-04	195	229	9	4250_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HG-U133A	MYO9A NFATC4 ACAN CDC42EP2 COBL POFUT2 HHLA1 EGR1 DIXDC1	1.66e-04	195	229	9	433_UP
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CDK17 EPS8L1 BAIAP3 ARAP1 BCL2L10 TNS2 FNDC3A CBL LPIN2	1.66e-04	195	229	9	6245_UP
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A	GABRB2 CDK17 PDLIM7 EPS8L1 ABCA7 GLP1R CD1C PAM GAA	1.66e-04	195	229	9	6200_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A	WIZ GLP1R ZNF324 FNDC3A NR3C1 ZNF365 EML3 PRF1 CSPP1	1.66e-04	195	229	9	5283_UP
Disease	myoglobinuria (implicated_via_orthology)	LPIN1 LPIN3 LPIN2	4.43e-07	3	226	3	DOID:0080108 (implicated_via_orthology)
Disease	Manic	TRANK1 HSPA4 ANK3 NR3C1 NCAN DIXDC1	3.06e-05	78	226	6	C0338831
Disease	platelet component distribution width	SAV1 SIGLEC5 TRANK1 PTPRH CLPB C4BPA GNAS HERC1 BRAT1 PRRC2A FOXO3 LNX2 KALRN SIGLEC14 ZBTB10 TNXB GAA	7.99e-05	755	226	17	EFO_0007984
Disease	leprosy	ANKS1B SIGLEC5 CCDC88B KIAA0319 KALRN WDR59	1.45e-04	103	226	6	EFO_0001054
Disease	glucose measurement	IL22RA1 PTPRJ GLP1R OLFM1 HERC1 ARAP1 ZAN ENTHD1 IFNLR1 DNLZ PAM	1.83e-04	380	226	11	EFO_0004468
Disease	lipid metabolism disorder (implicated_via_orthology)	LPIN1 LPIN3 LPIN2	1.88e-04	15	226	3	DOID:3146 (implicated_via_orthology)
Disease	Manic Disorder	TRANK1 ANK3 NR3C1 NCAN DIXDC1	2.18e-04	71	226	5	C0024713
Disease	obesity (implicated_via_orthology)	ESR2 LPIN1 DNAH10 SIM1 NR3C1 LPIN3 ZFHX4 LPIN2	2.68e-04	215	226	8	DOID:9970 (implicated_via_orthology)
Disease	alkaline phosphatase measurement	MAP1A SIGLEC9 DHX38 PRAG1 KIAA0319 RASIP1 CILP2 TRANK1 PTPRJ NFATC4 MYRF UTRN HSPA4 NBPF3 NCOA2 APBA3 PAPLN BCAS1 KIAA1614	3.30e-04	1015	226	19	EFO_0004533
Disease	lysophosphatidylcholine 20:1 measurement	OLFM1 FOXO3	3.47e-04	4	226	2	EFO_0021457
Disease	Depression, Bipolar	TRANK1 ANK3 NR3C1 NCAN DIXDC1	3.59e-04	79	226	5	C0005587
Disease	cortical thickness	NFILZ FAM178B SPTBN2 TNRC6B NCKAP5 ADGRV1 DYSF ZNF469 UMODL1 TNRC6A AGAP3 NCOA2 FOXO3 GALR3 KIAA1614 NR2F2 ADAMTS7 PAM PLCH1 EPHA7	3.88e-04	1113	226	20	EFO_0004840
Disease	hypertension (implicated_via_orthology)	ESR2 ACE PTPRJ GLP1R NR3C1 NR2F2	4.71e-04	128	226	6	DOID:10763 (implicated_via_orthology)
Disease	Congenital dyserythropoietic anemia	CDAN1 LPIN2	5.75e-04	5	226	2	C0002876
Disease	Insulinogenic index measurement	PPIP5K2 PAM	5.75e-04	5	226	2	EFO_0009961
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	5.75e-04	5	226	2	C0206630
Disease	cortical surface area measurement	NFILZ FAM178B TNRC6B NCKAP5 ADGRV1 DYSF ZNF469 TNRC6A PRRC2A AGAP3 NCOA2 FOXO3 ZAN ANK3 KIF26B BRSK2 KIAA1614 NR2F2 ADAMTS7 PAM TNXB EPHA7	7.05e-04	1345	226	22	EFO_0010736
Disease	mean platelet volume	SAV1 RCC2 RASIP1 TRANK1 PTPRJ TNRC6A C4BPA GNAS MCF2L ARAP1 LNX2 ZAN KALRN PCDHGA6 BCAS1 ZBTB10 ITPRIP NIN	9.32e-04	1020	226	18	EFO_0004584
Disease	eye measurement	RASIP1 ZNF469 HERC1	1.13e-03	27	226	3	EFO_0004731
Disease	thrombocytopenia (implicated_via_orthology)	PTPRJ FGA	1.20e-03	7	226	2	DOID:1588 (implicated_via_orthology)
Disease	Paroxysmal atrial fibrillation	ESR2 SYNPO2L ACE HERC1 DNAH10 NR3C1	1.32e-03	156	226	6	C0235480
Disease	familial atrial fibrillation	ESR2 SYNPO2L ACE HERC1 DNAH10 NR3C1	1.32e-03	156	226	6	C3468561
Disease	Persistent atrial fibrillation	ESR2 SYNPO2L ACE HERC1 DNAH10 NR3C1	1.32e-03	156	226	6	C2585653
Disease	cerebral infarction (is_implicated_in)	ACE MYRF KALRN	1.40e-03	29	226	3	DOID:3526 (is_implicated_in)
Disease	Atrial Fibrillation	ESR2 SYNPO2L ACE HERC1 DNAH10 NR3C1	1.50e-03	160	226	6	C0004238
Disease	resting heart rate, chronic obstructive pulmonary disease	SYNPO2L ADGRV1 HERC1	1.55e-03	30	226	3	EFO_0000341, EFO_0004351
Disease	mammographic density percentage, mammographic density measurement	TMEM184B ZNF365	1.59e-03	8	226	2	EFO_0005941, EFO_0006502
Disease	osteoarthritis	PRAG1 GRID2IP MCF2L MDFIC DNAH10 KIF26B FAM53A	1.68e-03	222	226	7	MONDO_0005178
Disease	body weight	CDK17 MBD1 ANKS1B TNRC6B MDGA2 ADGRV1 PTPRJ NFATC4 ACAN TNRC6A GNAS ARAP1 FOXO3 MDFIC RGS7BP SIM1 WDR59 EGR1 SCRIB ZRANB1	1.77e-03	1261	226	20	EFO_0004338
Disease	kallikrein-11 measurement	KLK11 KLK8	2.03e-03	9	226	2	EFO_0010573
Disease	chronic hepatitis C virus infection	RCC2 OLFM1 EPHA7	2.04e-03	33	226	3	EFO_0004220
Disease	blood phosphate measurement	FAM178B SPTBN2 PRAG1 NBPF3 FOXO3 BCAS1	2.30e-03	174	226	6	EFO_0010972
Disease	lung disease (biomarker_via_orthology)	ACE NR3C1 EGR1	2.42e-03	35	226	3	DOID:850 (biomarker_via_orthology)
Disease	asthma (implicated_via_orthology)	FGA NR3C1 PRF1	2.42e-03	35	226	3	DOID:2841 (implicated_via_orthology)
Disease	dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement	SIGLEC5 SIGLEC14	2.52e-03	10	226	2	EFO_0801544
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A NCAN	2.52e-03	10	226	2	EFO_0004530, EFO_0600007
Disease	chronic fatigue syndrome (is_marker_for)	IL16 PRF1	2.52e-03	10	226	2	DOID:8544 (is_marker_for)
Disease	membranoproliferative glomerulonephritis (biomarker_via_orthology)	MYOC PRF1	2.52e-03	10	226	2	DOID:2920 (biomarker_via_orthology)
Disease	lung cancer (is_implicated_in)	DAB2IP MBD1 ACE IRS4	2.54e-03	74	226	4	DOID:1324 (is_implicated_in)
Disease	aortic valve stenosis (is_marker_for)	ESR2 EGR1	3.07e-03	11	226	2	DOID:1712 (is_marker_for)
Disease	triacylglycerol 56:2 measurement	NFILZ ZFHX4	3.07e-03	11	226	2	EFO_0010429
Disease	osteosarcoma (is_marker_for)	CBL EGR1	3.07e-03	11	226	2	DOID:3347 (is_marker_for)
Disease	kidney cancer (implicated_via_orthology)	SAV1 SCRIB	3.07e-03	11	226	2	DOID:263 (implicated_via_orthology)
Disease	venous thromboembolism, factor VII measurement	PTPRJ C4BPA MCF2L	3.07e-03	38	226	3	EFO_0004286, EFO_0004619
Disease	verbal-numerical reasoning measurement	PDLIM7 TNRC6A NCOA2 FOXO3 ENTHD1	3.44e-03	131	226	5	EFO_0008394
Disease	basal cell carcinoma	ADGRV1 CCDC88B RCC2 ADAMTS12 ZBTB10 TSPYL5	3.46e-03	189	226	6	EFO_0004193
Disease	Schizophrenia	GABRB2 ESR2 SPTBN2 CHEK1 ACE NDUFV1 GNAS ANK3 NR3C1 PITPNM1 ADAMTS12 CSPG5 NCAN DIXDC1 TNXB	3.51e-03	883	226	15	C0036341
Disease	sialic acid-binding Ig-like lectin 14 measurement	SIGLEC5 SIGLEC14	3.66e-03	12	226	2	EFO_0008284
Disease	Pulmonary Thromboembolisms	DAB2IP FGA	3.66e-03	12	226	2	C0524702
Disease	Pulmonary Embolism	DAB2IP FGA	3.66e-03	12	226	2	C0034065
Disease	linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement	MYRF NCAN	3.66e-03	12	226	2	EFO_0800500
Disease	body composition measurement	TNRC6B DYSF HMCN2 ACAN WDR59 C11orf21	3.83e-03	193	226	6	EFO_0005106
Disease	Bipolar Disorder	GABRB2 ACE NDUFV1 TRANK1 HSPA4 ANK3 NR3C1 NCAN KLK8 DIXDC1	3.94e-03	477	226	10	C0005586
Disease	tonsillectomy risk measurement	NFILZ AJAP1 NCOA2 PHF23 LGI2 CSPP1 TNXB	4.05e-03	260	226	7	EFO_0007924
Disease	venous thromboembolism, von Willebrand factor measurement	PTPRJ C4BPA MYRF	4.08e-03	42	226	3	EFO_0004286, EFO_0004629
Disease	Muscular Dystrophy, Facioscapulohumeral	ACAN HSPA4	4.31e-03	13	226	2	C0238288
Disease	interleukin 17 measurement	ANKS1B PTPRJ UTRN	4.96e-03	45	226	3	EFO_0008174
Disease	rostral middle frontal gyrus volume measurement	BCL2L10 PLA2R1	5.00e-03	14	226	2	EFO_0010328
Disease	hematocrit	STK36 MYO9A ESR2 DHX38 TNRC6B ADGRV1 PTPRJ MYRF ZAN KALRN SIM1 NR3C1 CR1 CEP164 ZBTB10 PSD4	5.12e-03	1011	226	16	EFO_0004348
Disease	Sclerocystic Ovaries	CARMIL3 TNRC6B GNAS ADAMTS7 LTK	5.13e-03	144	226	5	C1136382
Disease	stroke	FGA KALRN ADAMTS12 EPHA7 NIN	5.13e-03	144	226	5	EFO_0000712
Disease	Polycystic Ovary Syndrome	CARMIL3 TNRC6B GNAS ADAMTS7 LTK	5.13e-03	144	226	5	C0032460
Disease	sexual dimorphism measurement	ESR2 DYSF SPTBN5 SSC5D TRANK1 NFATC4 ACAN C11orf68 TNRC6A HERC1 MYRF FOXO3 DNAH10 PHF23 NR3C1 CEP164 PPP6R3	5.27e-03	1106	226	17	EFO_0021796
Disease	Endogenous depression	GNAS NR3C1 DIXDC1	5.28e-03	46	226	3	C0011573
Disease	multiple sclerosis symptom measurement	NCOA2 DNAH10 EPHA7	5.28e-03	46	226	3	EFO_0803536
Disease	comparative body size at age 10, self-reported	ANKS1B TNRC6B ACAN TNRC6A GNAS RGS7BP SIM1 GPR61 PPP6R3	5.32e-03	420	226	9	EFO_0009819
Disease	C-reactive protein measurement	HIP1 MAP1A SIGLEC9 PRAG1 IL22RA1 ZNF469 CILP2 TRANK1 EME2 ARAP1 NBPF3 ANK3 PRR30 CBL EML3 IFNLR1 EPHA7 PSD4	5.57e-03	1206	226	18	EFO_0004458
Disease	acute graft vs. host disease, donor genotype effect measurement	MDGA2 KALRN	5.74e-03	15	226	2	EFO_0004599, EFO_0007892
Disease	response to olanzapine	ANKS1B ADGRV1	5.74e-03	15	226	2	GO_0097333
Disease	waist circumference	ESR2 FAM178B ANKS1B DGKQ PRRC2A ARAP1 FOXO3 DNAH10 GPR61	6.09e-03	429	226	9	EFO_0004342
Disease	multisite chronic pain	GABRB2 MLN UTRN KNDC1	6.20e-03	95	226	4	EFO_0010100
Disease	cognitive function measurement, self reported educational attainment	PDLIM7 PTPRJ TNRC6A FOXO3 ENTHD1 FAM193A PAM TNXB	6.30e-03	355	226	8	EFO_0004784, EFO_0008354
Disease	preeclampsia, hypertension, pregnancy-induced	RGL3 TNS2	6.53e-03	16	226	2	EFO_0000668, MONDO_0024664
Disease	alcohol use disorder measurement, alcohol consumption measurement	RASIP1 PTPRJ TNRC6A PLCH1	6.66e-03	97	226	4	EFO_0007878, EFO_0009458
Disease	chronic obstructive pulmonary disease (is_marker_for)	IL16 HSPA4 NR3C1 EGR1	6.66e-03	97	226	4	DOID:3083 (is_marker_for)
Disease	eye colour measurement	MDGA2 ZNF469 MDFIC SIM1 GPR61 ZRANB1	6.86e-03	218	226	6	EFO_0009764
Disease	Acute Confusional Senile Dementia	ACE ABCA7 CR1 EPHA1	7.15e-03	99	226	4	C0546126
Disease	Alzheimer's Disease, Focal Onset	ACE ABCA7 CR1 EPHA1	7.15e-03	99	226	4	C0750900
Disease	Alzheimer Disease, Early Onset	ACE ABCA7 CR1 EPHA1	7.15e-03	99	226	4	C0750901
Disease	Presenile dementia	ACE ABCA7 CR1 EPHA1	7.15e-03	99	226	4	C0011265
Disease	Alzheimer Disease, Late Onset	ACE ABCA7 CR1 EPHA1	7.15e-03	99	226	4	C0494463
Disease	sex interaction measurement, ulcerative colitis	ZNF365 TNXB	7.36e-03	17	226	2	EFO_0000729, EFO_0008343
Disease	alpha-L-iduronidase measurement	DGKQ FAM53A	7.36e-03	17	226	2	EFO_0020139
Disease	glomerulonephritis (implicated_via_orthology)	ACE PRF1	7.36e-03	17	226	2	DOID:2921 (implicated_via_orthology)
Disease	Familial Alzheimer Disease (FAD)	ACE ABCA7 CR1 EPHA1	7.41e-03	100	226	4	C0276496
Disease	coronary artery disease (is_implicated_in)	ESR2 ACE KALRN NR3C1	7.41e-03	100	226	4	DOID:3393 (is_implicated_in)
Disease	glucose metabolism measurement, age-related hearing impairment	DAB2IP ZNF469 EPHA7	7.43e-03	52	226	3	EFO_0005782, EFO_0009367

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTWLRNEDSGPSGSV	UMODL1	671	Q5DID0
PTLSRDTSPLGGQSW	nan	131	Q8NBF4
GPWLSGPQGTDRDQS	AMER3	326	Q8N944
SADQWSEATTSLPPG	AGAP3	501	Q96P47
SAICQGDGTWSPRTP	C4BPA	406	P04003
TQLSLRWEPPADTGG	EPHA1	346	P21709
TWAGSRPRSPGANLT	EPHA1	466	P21709
GSPNTASAEATLPRW	BRAT1	741	Q6PJG6
GVPNSDEGYWDSTTP	AMER2	516	Q8N7J2
SGDGPSVSWSRQTQP	CCDC61	376	Q9Y6R9
GSGVPWASRPEATLQ	DISP3	811	Q9P2K9
ASDWSPQESGSPVET	CCDC88B	571	A6NC98
SPLEVWLNLGGSTPD	CSPG5	171	O95196
SSQPEPRTGLSLWDT	CHEK1	316	O14757
LSDSPGPTWGRVVTL	BCL2L10	86	Q9HD36
WTPNSARSEGPLPDS	ACE	1226	P12821
EEPNSSSWRGELSTP	BAIAP3	421	O94812
GIDIWTASNPLPTSG	ADAM20	256	O43506
TEGTDSPLSRDWRPG	DIXDC1	256	Q155Q3
VTGWGATDPDSLRPS	GZMK	151	P49863
TTLPNDSPFGLVGWR	ADGRV1	3766	Q8WXG9
GSRPTTETEFIAWGP	AJAP1	171	Q9UKB5
EQEGSRSSSSSPEPW	APBA3	161	O96018
SPGSGEATPEAWVIR	DGKQ	376	P52824
SWQGLEPRLGQTPVT	DPH2	456	Q9BQC3
DSPEAPRRSFAGGTW	ANKIB1	736	Q9P2G1
ITQWGEESSGSSPLP	PAM	666	P19021
QSSTASADPSIWGDP	DENND1C	656	Q8IV53
EAQTGEGSWPRSPSK	DMWD	641	Q09019
EGSWPRSPSKSVVEG	DMWD	646	Q09019
SQPSALDTSPWGLGL	CDAN1	226	Q8IWY9
WNPGTFLPDTISGSE	FAM193A	541	P78312
GSGLSSSRNPITWPV	ADAMTS12	1126	P58397
ARRGNWENLTSPGPT	ADAMTS7	771	Q9UKP4
SSPSPDVAELWTGGT	ADAMTS7	1251	Q9UKP4
SVRGPSSTVGPSLNW	ABCA7	226	Q8IZY2
PPLQSGDWERRGSGS	RGS7BP	26	Q6MZT1
ADESTISWGPSPTFG	RCC2	446	Q9P258
ADSEGTGAPSWRPQK	RASIP1	271	Q5U651
WTGLATSPRSPQESA	NFILZ	161	A0A5F9ZHS7
STWRDPQDEVPGSQG	NR2F2	6	P24468
PEPGLSDSAAASQWS	INSYN2A	266	Q6ZSG2
PREPSEGTPASSTDW	ITPRIP	366	Q8IWB1
SGPGPTQGSWERQLL	P3H3	101	Q8IVL6
EDSLGGWALVSPETP	ARHGEF17	686	Q96PE2
AQTGDWGEPSITLRP	ANKS1B	1021	Q7Z6G8
GTLASASPDWVGPST	DAB2IP	951	Q5VWQ8
VREATSNDPWGPSSS	ENTHD1	21	Q8IYW4
PDPGSARSTWLGILS	MUC16	1141	Q8WXI7
QGNSTWPAPAEETGS	MUC16	3176	Q8WXI7
TPGATSQGILPWDTS	MUC16	5571	Q8WXI7
GEWPPQASLSAGELT	LPIN3	206	Q9BQK8
PPERSSLIQDWETSG	NUP98	1676	P52948
ITPGIGNETWGDPRV	PTPRJ	186	Q12913
WVTASDSGDPPLSSN	PCDHGA6	531	Q9Y5G7
QGTGCPSESWVSRPL	GPR61	386	Q9BZJ8
GAWPEGAERSSRPDT	MAP1A	2391	P78559
EGGPGRQTTSPNVLW	ESR2	66	Q92731
PISLRWNSPAEEGSS	HSPA4	401	P34932
IWGNPSDGELIRTQP	MDFIC	61	Q9P1T7
RAPLVPSEGSSAWDS	IFNLR1	371	Q8IU57
AGPRPQGATVSLWET	GLP1R	21	P43220
PTVTWERDGQPVGAE	HMCN2	2296	Q8NDA2
ARGSPTPRIGWTVND	HMCN2	4146	Q8NDA2
STGVRWVDGPLRSSP	KIF26B	1966	Q2KJY2
EGPATAWSGESPELL	HERC1	3536	Q15751
GTSAVEWSGPEPQLD	KIAA1614	31	Q5VZ46
SLSTWSEEPGLDNPA	LNX2	196	Q8N448
SSPSVGGVPWRARLN	BRSK2	466	Q8IWQ3
QPTASGSWEGLSELP	CARMIL3	951	Q8ND23
GNTLWPEPLFSLVSG	EGR1	146	P18146
LPSVWSESEDGAGSP	MBD1	386	Q9UIS9
ASPLNSPGTEGSWLF	LTK	56	P29376
GWTSRAPSPQAGRSL	LTK	276	P29376
SAWVNSLPGSPGLVD	PRF1	326	P14222
DRSTGVLPTNPEESW	OLFM1	46	Q99784
GSNSVATEPWLRPGT	CSPP1	1206	Q1MSJ5
SSTEGEPGWRRASPV	IL16	671	Q14005
RVSASNPWGISLPSE	KALRN	2641	O60229
WGSTPTEQGRPRTVK	DDHD2	181	O94830
PWIQTPGDAELTRTG	RIPPLY3	41	P57055
PPGSREVSTWNLDTL	MYOC	196	Q99972
SPSKGPVDWSRENST	KIF24	911	Q5T7B8
PVDWSRENSTSSGPS	KIF24	916	Q5T7B8
ISGWGSTSSPQLRLP	KLK11	176	Q9UBX7
STWDSTAAGLGPEPQ	LRRC75B	296	Q2VPJ9
NSDREWSPTPSPSGS	LPIN1	231	Q14693
EPTELTGWPITRVGN	LRRC52	216	Q8N7C0
WDPTGNLSPTRRTTN	GABRB2	376	P47870
SGSPGKETNESPWRS	NR3C1	201	P04150
RPWPQLDTGSPESSG	LMNTD2	241	Q8IXW0
GTPSQETWPGISSNE	CDK17	406	Q00537
TVTHPERPWDQGGIT	POMGNT2	401	Q8NAT1
TGGQAPSREISLGPW	PRR25	51	Q96S07
WSQRDRPGAAGASPT	RGL3	276	Q3MIN7
TVSLEWSPPADNGGR	EPHA7	346	Q15375
NTEDWRPRPGTGQSR	PDLIM7	151	Q9NR12
TTGGEPAPSLTWVRS	MDGA2	266	Q7Z553
SGLPSGDEERIEWPS	ACAN	916	P16112
ARDGGSPPLWATASV	PCDHA10	426	Q9Y5I2
QWTLRGPDVETSPFG	NBPF3	11	Q9H094
QEESSWGGSPSPVRL	OTOP1	516	Q7RTM1
TLLSSSRTGGQAPPW	GASK1A	246	Q9UFP1
GPSAWQEPGSTTDLF	GALR3	46	O60755
DEGGISWVTSNRDPP	DNAJB7	266	Q7Z6W7
TVGRWARVEGTPSDP	GMPPA	346	Q96IJ6
AQTRSRSQPPDGAWG	APBB3	151	O95704
RWSGAQPLEQPSGSV	ARAF	456	P10398
GPRTLSGVSWPSERL	GRID2IP	591	A4D2P6
GSVDIWRIPETGSPN	CDC42EP2	146	O14613
AAGRRVSPSPGTWLE	C6orf141	226	Q5SZD1
PEAWLSSRPSLGSGQ	CD1C	206	P29017
TSNDDQVGIWSGPAP	CR1	216	P17927
TSNDDQVGIWSGPAP	CR1	666	P17927
TSNDDQVGIWSGPAP	CR1	1116	P17927
WRRSSSEQGPGPAAA	DNLZ	46	Q5SXM8
DSWGTDAGNPTPQRL	GAS2L2	426	Q8NHY3
WSPPSSLINGETDES	FNDC3A	286	Q9Y2H6
DGNETDSIWPPSIFG	COBL	1076	O75128
TQPRSSPSGREASLW	GPAT2	11	Q6NUI2
GTSPAQWEDITGTTP	ANK3	1251	Q12955
VLQPSPALSWRSTGG	GAA	321	P10253
SETESPRNPSSAGSW	FGA	281	P02671
RDPTTGKEGWVPASS	MCF2L	1096	O15068
SDGPGAAQEPTWLTD	ERP27	31	Q96DN0
ENILTWDSGPEGTPD	IL22RA1	36	Q8N6P7
PWTEQSLGPERGDQV	GPR156	491	Q8NFN8
GWGTVTSPRENFPDT	KLK8	156	O60259
SESSWRERPAPGNAG	KNDC1	211	Q76NI1
SAPSSSDPWTGRELT	CBL	601	P22681
ETLPGQDSWNGVPSR	CLPB	96	Q9H078
ASEDGPLNSRAISPW	IL25	76	Q9H293
SSQGITLTWTAPRGP	IGFN1	756	Q86VF2
GDSEGNILTWGRSPS	EML3	476	Q32P44
GGSGQRRPPTWEISD	EME2	21	A4GXA9
STLGPSEEQEESWPG	EMILIN1	416	Q9Y6C2
SLEGLLESPSPGTSW	HILPDA	26	Q9Y5L2
SLGDSWTRPGLELSP	EPS8L1	396	Q8TE68
ESWTLPVAAGPGQDT	BCAS1	136	O75363
SRWGSQGLPPDELSV	DNAH10	3406	Q8IVF4
LQETAREGSSISPPW	FAM53C	316	Q9NYF3
AWFPLTRGSQPSGEL	DYSF	1256	O75923
RAGAEVSWEVSSPGP	PRRT3	291	Q5FWE3
PSTQGLPDSWGIIAE	IRS4	936	O14654
QDRPPSLGSWASILD	FAM180B	166	Q6P0A1
PGPGLRVSGEQSLTW	NUTM2A	836	Q8IVF1
PGPGLRVSGEQSLTW	NUTM2B	836	A6NNL0
WPGSPTSRSSDELDA	FOXO3	291	O43524
PPSQGDSRVSSPSWE	SYNPO2L	191	Q9H987
PQTGDLSAEWPFTAG	HHLA1	411	C9JL84
PESDSRINGVSPWAS	UTRN	3356	P46939
EATWGRVPSDPFTGV	UBOX5	296	O94941
LTDEIPWGSSRDPGT	STAP2	71	Q9UGK3
SWGEPSSPSTLVDNG	TNRC6C	816	Q9HCJ0
SSLWGPPSADDSRVI	TNRC6C	1656	Q9HCJ0
QQSTLEPGPTWRGGA	TMEM184B	366	Q9Y519
GSSWVPRIVPGDISS	LGI2	51	Q8N0V4
PLPDWGSEVAATGTQ	NCKAP5	1846	O14513
ASQSGSSPPQDWIEE	NIN	171	Q8N4C6
SPGTWESQPARSVRL	NFATC4	81	Q14934
LGAVSWPPASASGQE	POFUT2	11	Q9Y2G5
WDNLLAVIPGGSSTP	NDUFV1	311	P49821
QLLTWPPETSLGAFG	FAM178B	331	Q8IXR5
WVPGAIGSPSQEAVR	GNAS	276	Q5JWF2
APSDASGIWEPGSQV	NCAN	836	O14594
EGWEEGTEASPPTLQ	HIP1	1016	O00291
EGQAWLREGTPDSSP	PSD4	221	Q8NDX1
LREGTPDSSPQWGAE	PSD4	226	Q8NDX1
GPSLRPQNSTTWRDG	PRRC2A	196	P48634
WGGSPLTDTASPQLL	SIM1	406	P81133
EAGPPLTFSWTGNAL	SIGLEC5	171	O15389
RGSASQGPLTEPWAE	SIGLEC9	396	Q9Y336
EGLAQPSEWGLPTSA	WIZ	196	O95785
GSLSETWSDAPPSRV	SCRIB	431	Q14160
PELGQGSSPWLLFTS	IL9R	71	Q01113
DFSSGPPSATGRELW	IMPG2	436	Q9BZV3
NSRDDSTSPLDGAPW	SSC5D	126	A1L4H1
STERPAASGGWAAPQ	FAM110D	126	Q8TAY7
GTPTDQSNWGIRKPD	PLA2R1	1331	Q13018
WAKSGTGEVPSAPRE	STK36	366	Q9NRP7
LLPGGRQPSSSSWDS	SPTBN5	3546	Q9NRC6
EVRSQRPWSGAPETS	ARAP1	1316	Q96P48
WDSGQGPRLPSSVAQ	CEP164	1336	Q9UPV0
VVPFREGTPASWTGD	CILP2	911	Q8IUL8
WPLGPLGSSSQDSIL	CLEC19A	121	Q6UXS0
LSSQSGVEPPDRWTG	C11orf21	26	Q9P2W6
WEALQTSGRPITPGT	C11orf68	141	Q9H3H3
VNGGSWSGEPPRRNS	NCOA2	181	Q15596
RPVQPTWEGSSEAGL	RHBDD3	261	Q9Y3P4
AGGLDWPEATEVSPS	PKP3	226	Q9Y446
SWGPDREALAPNSLS	INPP5J	976	Q15735
PLSDDWARTAAQTGP	PITPNM1	171	O00562
LPPGWERVESSEFGT	SAV1	236	Q9H4B6
APRSSGLSLPGSAWQ	ZNF503-AS2	96	A6NEH8
PAPEENLTWSSSGGD	USP51	66	Q70EK9
TNLIGPDPTFRGLWS	ZFHX4	351	Q86UP3
GEEPWVPSGTDTTLS	ZNF324	56	O75467
SGSSFGPTDWLPQTL	ZC3H12A	411	Q5D1E8
LSVWQRSGEEGPVDP	MLN	51	P12872
QTASDTTWDGTQPRP	SPTBN2	2116	O15020
VSGTPQPSLRWFRDG	SPEG	66	Q15772
SPGELGTTPWEESTN	PIK3R5	591	Q8WYR1
LGPQESPASDSRGQW	PAPLN	561	O95428
LGPRTLQVSWTVDGP	ROBO3	681	Q96MS0
GDGNSSITVSWEPPL	ROBO3	781	Q96MS0
PEGSSWSLLDTPGEV	TECPR1	231	Q7Z6L1
TGENSFRSLTWPPSG	SP100	176	P23497
TPDSLRLSWTVPEGQ	TNXB	1686	P22105
VTTSSLRLNWEAPPG	TNXB	3666	P22105
LLTEESPSGRGWPSQ	TTC3	2001	P53804
RGPAAVWGSPVTETQ	PRRT4	61	C9JH25
GEARPAWVPGSAETS	TBC1D10B	56	Q4KMP7
GYGSSRRSQWESPSP	DHX38	221	Q92620
SAVAGTGPPRALWSE	PRPF40B	86	Q6NWY9
EGPVLSTSWRPGDSA	SLAMF9	181	Q96A28
VWEQSVGSLGSRPPL	YJU2	246	Q9BW85
DWPASGSSSPLRGES	PHF23	56	Q9BUL5
ASGWGRDSPDPTPQV	PRAG1	456	Q86YV5
WPRGPVSQNSEVGEE	PRAG1	501	Q86YV5
ESNLPGSPNTSRGWL	PLCH1	1301	Q4KWH8
VDENTAPGTSGAPSW	TOP3A	936	Q13472
WEGLSGAATPAPTVR	ZNF446	291	Q9NWS9
LLQGEGSPLEDPSSW	ZNF469	2186	Q96JG9
SPWGESSPEELRFGS	WDR59	816	Q6PJI9
DLDGTSWRDPGPAQS	ZNF445	136	P59923
KEGESSRGTEPLWTP	TSSK1B	286	Q9BXA7
PGQTGSDVTVSWSPE	ZNF213	261	O14771
SASPWPTGSNRDVVL	ZNF365	91	Q70YC4
NGSSRGRPETSVWPL	ZBTB10	136	Q96DT7
ESPLSVSSPEGTGTW	PPIP5K2	976	O43314
SASDDGTVRIWGPAP	WDR26	631	Q9H7D7
RTLPEGSAVPDSWET	TRANK1	651	O15050
GSAVPDSWETLPGTQ	TRANK1	656	O15050
LPGRPTWGFSQLVDS	PRR30	16	Q53SZ7
TGADTTPGWEVAVRP	UBR4	21	Q5T4S7
TTWGVLDPPVGNTRL	PPP6R3	331	Q5H9R7
LSWEVPDGTDPQNST	PTPRH	226	Q9HD43
EAGPPLTFSWTGNAL	SIGLEC14	171	Q08ET2
DTSSVSGWGDPKPAL	TNRC6A	776	Q8NDV7
SAESLEPVSWREGPS	TNS2	871	Q63HR2
SSTDPQDRRWTNPDG	TNS2	1346	Q63HR2
RDWDPSSTEGGSSPL	ZRANB1	51	Q9UGI0
GGRPDEKTPSSWNEN	TNRC6B	711	Q9UPQ9
GPSGQVVSRSTPIQW	TSPYL5	316	Q86VY4
EDWVRASGPSPTGST	ZAN	61	Q9Y493
GAVLPRSAVWSTGPT	FAM53A	166	Q6NSI3
LNRGSPSGIWGDSPE	KIAA0319	121	Q5VV43
EPGSRQWPESDTLSG	LPIN2	426	Q92539
WSTELVPEGLQSPRG	MYO9A	1306	B2RTY4
RGALQSSVGPAEPTW	MYRF	986	Q9Y2G1